Document:

EX-10.12

 Exhibit 10.12 

INDEMNIFICATION AGREEMENT 

THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into as of
[                ], 2020 between Maravai LifeSciences Holdings, Inc., a Delaware corporation (the “Company”), and
[                ] (“Indemnitee”). 

WHEREAS, highly competent persons have become more reluctant to serve corporations as directors or officers or in other capacities unless they
are provided with adequate protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of the corporation; 

WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified
individuals, the Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. Although the furnishing of such insurance has been
a customary and widespread practice among United States-based corporations and other business enterprises, the Company believes that, given current market conditions and trends, such insurance may be available to it in the future only at higher
premiums and with more exclusions. At the same time, directors, officers and other persons in service to corporations or business enterprises are being increasingly subjected to expensive and time-consuming litigation relating to, among other
things, matters that traditionally would have been brought only against the corporation or business enterprise itself. The Bylaws of the Company (as amended or restated, the “Bylaws”) require indemnification of the officers and
directors of the Company. Indemnitee may also be entitled to indemnification pursuant to the General Corporation Law of the State of Delaware (“DGCL”). The Bylaws and the DGCL expressly provide that the indemnification provisions
set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers of the Company and other persons with respect to indemnification; 

WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such
persons; 
 WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the
best interests of the Company and its stockholders and that the Company should act to assure such persons that there will be increased certainty of such protection in the future; 

WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, and to advance expenses on
behalf of, such persons to the fullest extent permitted by applicable law so that they will serve or continue to serve the Company free from undue concern that they will not be so indemnified; 

WHEREAS, this Agreement is a supplement to and in furtherance of the Bylaws and any resolutions adopted pursuant thereto, and shall not be
deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; [and] 

 WHEREAS, Indemnitee may not be willing to serve or continue to serve as an officer or director
without adequate protection, and the Company desires Indemnitee to serve or continue to serve in such capacity; Indemnitee is willing to serve, continue to serve and take on additional service for or on behalf of the Company on the condition that he
be so indemnified[; and] 
 [WHEREAS, Indemnitee has certain rights to indemnification and/or insurance provided by GTCR, LLC
(“GTCR”) or affiliates of GTCR which Indemnitee and GTCR intend to be secondary to the primary obligation of the Company to indemnify Indemnitee as provided herein, with the Company’s acknowledgment of and agreement to the
foregoing being a material condition to Indemnitee’s willingness to serve on the Board.]1 

NOW, THEREFORE, in consideration of Indemnitee’s agreement to serve as a director or officer from and after the date hereof, the parties
hereto agree as follows: 
 1. Indemnity of Indemnitee. Subject to the provisions of Section 9, the Company
hereby agrees to hold harmless and indemnify Indemnitee to the fullest extent permitted by law, as such may be amended from time to time, if Indemnitee was or is, or is threatened to be made, a party to, or otherwise becomes involved in, any
Proceeding (as hereinafter defined) by reason of Indemnitee’s Corporate Status (as hereinafter defined). In furtherance of the foregoing indemnification, and without limiting the generality thereof: 

(a) Proceedings other than Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification
provided in this Section l(a) if, by reason of his Corporate Status, Indemnitee is, or is threatened to be made, a party to or participant, or otherwise becomes involved in, in any Proceeding (as hereinafter defined) other
than a Proceeding by or in the right of the Company. Pursuant to this Section 1(a), Indemnitee shall be indemnified against all Expenses, judgments, penalties, fines and amounts paid in settlement actually and reasonably
incurred by him, or on his behalf, in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the
Company, and with respect to any criminal Proceeding, had no reasonable cause to believe Indemnitee’s conduct was unlawful. 
 (b)
Proceedings by or in the Right of the Company. Indemnitee shall be entitled to the rights of indemnification provided in this Section 1(b) if, by reason of his Corporate Status, Indemnitee is, or is threatened to be
made, a party to or participant in any Proceeding brought by or in the right of the Company. Pursuant to this Section 1(b), Indemnitee shall be indemnified against all Expenses actually and reasonably incurred by
Indemnitee, or on Indemnitee’s behalf, in connection with such Proceeding if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests of the Company; provided,
however, if applicable law so provides, no indemnification against such Expenses shall be made in respect of any claim, issue or matter in such Proceeding as to which Indemnitee shall have been finally adjudged by a court to be liable to the
Company unless and only to the extent that the court in which the Proceeding was brought shall determine that Indemnitee is fairly and reasonably entitled to indemnification. 

 

	1 	 Bracketed language to be included in form for GTCR directors. 

  
 2 

 (c) Indemnification for Expenses of a Party Who is Wholly or Partly Successful.
Notwithstanding any other provision of this Agreement, to the extent that Indemnitee is, by reason of his Corporate Status, a party to or participant in and is successful, on the merits or otherwise, in any Proceeding or in defense of any claim,
issue or matter therein, in whole or in part, he shall be indemnified to the maximum extent permitted by law, as such may be amended from time to time, against all Expenses actually and reasonably incurred by him or on his behalf in connection
therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such Proceeding, the Company shall indemnify Indemnitee against all
Expenses actually and reasonably incurred by him or on his behalf in connection with each successfully resolved claim, issue or matter. For purposes of this Section 1(c) and without limitation, the termination of any claim,
issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter. 

2. Additional Indemnity. In addition to, and without regard to any limitations on the indemnification provided for in
Section 1 of this Agreement, the Company shall and hereby does, to the fullest extent permitted by applicable law, indemnify and hold harmless Indemnitee against all Expenses, judgments, penalties, fines and amounts paid in
settlement actually and reasonably incurred by him or on his behalf if, by reason of his Corporate Status, he is, or is threatened to be made, a party to or participant in any Proceeding (including a Proceeding by or in the right of the Company).
The only limitation that shall exist upon the Company’s obligations pursuant to this Agreement, other than those set forth in Section 9 hereof, shall be that the Company shall not be obligated to make any payment to
Indemnitee that is finally determined (under the procedures, and subject to the presumptions, set forth in Sections 6 and 7 hereof) to be unlawful. 

3. Contribution. 
 (a)
Whether or not the indemnification provided in Sections 1 and 2 hereof is available, in respect of any threatened, pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be if
joined in such action, suit or proceeding), to the fullest extent permitted by applicable law, the Company shall pay, in the first instance, the entire amount of any judgment or settlement of such action, suit or proceeding without requiring
Indemnitee to contribute to such payment and the Company hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Company shall not, without the Indemnitee’s prior written consent, enter into any such
settlement of any action, suit or proceeding (in whole or in part) unless such settlement (i) provides for a full and final release of all claims asserted against Indemnitee and (ii) does not impose any Expense, judgment, fine, penalty or
limitation on Indemnitee. 
 (b) Without diminishing or impairing the obligations of the Company set forth in the preceding subparagraph,
if, for any reason, Indemnitee shall elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed action, suit or proceeding in which the Company is jointly liable with Indemnitee (or would be
if joined in such action, suit or proceeding), to the fullest extent permitted by applicable law, the Company shall contribute to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred and paid or
payable by Indemnitee in proportion to the 

  
 3 

 
relative benefits received by the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such
action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, from the transaction from which such action, suit or proceeding arose; provided, however, that the proportion determined on the basis of relative benefit
may, to the extent necessary to conform to law, be further adjusted by reference to the relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be
if joined in such action, suit or proceeding), on the one hand, and Indemnitee, on the other hand, in connection with the events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other equitable considerations
which the law may require to be considered. The relative fault of the Company and all officers, directors or employees of the Company, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such action, suit or
proceeding), on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which their actions were motivated by intent to gain personal profit or advantage, the degree to which their
liability is primary or secondary and the degree to which their conduct is active or passive. 
 (c) To the fullest extent permitted by
applicable law, the Company hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought by officers, directors or employees of the Company, other than Indemnitee, who may be jointly liable with
Indemnitee. 
 (d) To the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is
unavailable to Indemnitee for any reason whatsoever, the Company, in lieu of indemnifying Indemnitee, shall contribute to the amount incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in
settlement and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect
(i) the relative benefits received by the Company and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding, and/or (ii) the relative fault of the Company (and its directors, officers, employees and
agents) and Indemnitee in connection with such event(s) and/or transaction(s). 
 4. Indemnification for Expenses of a Witness.
Notwithstanding any other provision of this Agreement, to the fullest extent permitted by applicable law and to the extent that Indemnitee is, by reason of his Corporate Status, a witness, is made (or asked) to respond to discovery requests, or is
otherwise asked to participate, in any Proceeding to which Indemnitee is not a party, he shall be indemnified against all Expenses actually and reasonably incurred by him or on his behalf in connection therewith. 

5. Advancement of Expenses. Notwithstanding any other provision of this Agreement (other than Section 7(e)
and Section 9), the Company shall advance, to the extent not prohibited by law, all Expenses incurred by or on behalf of Indemnitee in connection with any Proceeding (or part of any Proceeding) not initiated by Indemnitee
or any Proceeding initiated by Indemnitee with the prior approval of the Board as provided in Section 9(d), within thirty (30) days after the receipt by the Company of a statement or statements from Indemnitee
requesting such advance or advances from time to time, whether prior to or after final disposition of such 

  
 4 

 
Proceeding. Such statement or statements shall reasonably evidence the Expenses incurred by Indemnitee. Any advances pursuant to this Section 5 shall be unsecured and
interest free. In accordance with Sections 7(d) and 7(e) of this Agreement, advances shall include any and all reasonable Expenses incurred pursuing an action to enforce this right of advancement, including Expenses incurred preparing
and forwarding statements to the Company to support the advances claimed. This Section 5 shall not apply to claim by Indemnitee for expenses in a matter for which indemnity and advancement of expenses is excluded pursuant
to Section 9. 
 6. Procedures and Presumptions for Determination of Entitlement to Indemnification. It is
the intent of this Agreement to secure for Indemnitee rights of indemnity that are as favorable as may be permitted under the DGCL and public policy of the State of Delaware. Accordingly, the parties agree that the following procedures and
presumptions shall apply in the event of any question as to whether Indemnitee is entitled to indemnification under this Agreement: 
 (a)
To obtain indemnification under this Agreement, Indemnitee shall submit to the Company a written request, including therein or therewith such documentation and information as is reasonably available to Indemnitee and is reasonably necessary to
determine whether and to what extent Indemnitee is entitled to indemnification. The Secretary of the Company shall, promptly upon receipt of such a request for indemnification, advise the Board in writing that Indemnitee has requested
indemnification. Notwithstanding the foregoing, any failure of Indemnitee to provide such a request to the Company, or to provide such a request in a timely fashion, shall not relieve the Company of any liability that it may have to Indemnitee
unless, and to the extent that, such failure actually and materially prejudices the interests of the Company. 
 (b) Upon written request
by Indemnitee for indemnification pursuant to the first sentence of Section 6(a) hereof, a determination with respect to Indemnitee’s entitlement thereto shall be made in the specific case by one of the following four
methods, which shall be at the election of the Board: (1) by a majority vote of the Disinterested Directors (as hereinafter defined), even though less than a quorum; (2) by a committee of Disinterested Directors designated by a majority
vote of the Disinterested Directors, even though less than a quorum; (3) if there are no Disinterested Directors, or if the Disinterested Directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be
delivered to Indemnitee; or (4) if so directed by the Board, by the stockholders of the Company; provided, however, that if a Change in Control has occurred, the determination with respect to Indemnitee’s entitlement to
indemnification shall be made by Independent Counsel. For purposes hereof, Disinterested Directors are those members of the Board who are not parties to the action, suit or proceeding in respect of which indemnification is sought by Indemnitee. 

(c) In the event the determination of entitlement to indemnification is to be made by Independent Counsel, the Independent Counsel shall be
selected as provided in this Section 6(c). If a Change in Control has not occurred, the Independent Counsel shall be selected by the Board, and the Company shall give written notice to the Indemnitee advising him of the
identity of the Independent Counsel so selected. Indemnitee may, within 10 days after such written notice of selection shall have been given, deliver to the Company a written objection to such selection; provided, however, that such
objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as 

  
 5 

 
defined in Section 12 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion. Absent a proper and timely objection,
the Person so selected shall act as Independent Counsel. If a written objection is made and substantiated, the Independent Counsel selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court has determined
that such objection is without merit. If a Change in Control has occurred, the Independent Counsel shall be selected by the Indemnitee (unless the Indemnitee shall request that such selection be made by the Board, in which event the preceding
sentence shall apply), and approved by the Board within 20 days after notification by Indemnitee. If (i) an Independent Counsel is to make the determination of entitlement pursuant to this Section 6, and
(ii) within 20 days after submission by Indemnitee of a written request for indemnification pursuant to Section 6(a) hereof, no Independent Counsel shall have been selected (including as a result of an objection to the
selected Independent Counsel), either the Company or Indemnitee may petition the Court of Chancery of the State of Delaware or other court of competent jurisdiction for resolution of any objection which shall have been made by Indemnitee to the
Company’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a Person selected by the court or by such other Person as the court shall designate, and the Person with respect to whom all objections are so
resolved or the Person so appointed shall act as Independent Counsel under Section 6(b) hereof. The Company shall pay any and all reasonable fees and expenses of Independent Counsel incurred by such Independent Counsel in
connection with acting pursuant to Section 6(b) hereof, and the Company shall pay all reasonable fees and expenses incident to the procedures of this Section 6(c), regardless of the manner in which
such Independent Counsel was selected or appointed. 
 (d) In making a determination with respect to entitlement to indemnification
hereunder, the Person making such determination shall to the fullest extent permitted by law presume that Indemnitee is entitled to indemnification under this Agreement. Anyone seeking to overcome this presumption shall have the burden of proof to
overcome such presumption. Neither the failure of the Company (including by its directors or independent legal counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper in
the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by its directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be
a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct. 
 (e) Indemnitee shall be
deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise (as hereinafter defined), including financial statements, or on information supplied to Indemnitee by the officers of the
Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise or on information or records given or reports made to the Enterprise by an independent certified public accountant or by an appraiser or other expert
selected with reasonable care by the Enterprise. In addition, the knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to
indemnification under this Agreement. Whether or not the foregoing provisions of this Section 6(e) are satisfied, it shall in any event be presumed that Indemnitee has at all times acted in good faith and in a manner he
reasonably believed to be in or not opposed to the best interests of the Company. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. 

  
 6 

 (f) If the Person empowered or selected under this Section 6 to
determine whether Indemnitee is entitled to indemnification shall not have made a determination within sixty (60) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall to
the fullest extent permitted by law be deemed to have been made and Indemnitee shall be entitled to such indemnification absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make
Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law; provided, however, that such 60-day period may be extended for a reasonable time, not to exceed an additional thirty (30) days, if the Person making such determination with respect to entitlement to indemnification in good faith requires
such additional time to obtain or evaluate documentation and/or information relating thereto; and provided, further, that the foregoing provisions of this Section 6(f) shall not apply if the determination of
entitlement to indemnification is to be made by the stockholders pursuant to Section 6(b) of this Agreement and if (A) within fifteen (15) days after receipt by the Company of the request for such determination,
the Board or the Disinterested Directors, if appropriate, resolve to submit such determination to the stockholders for their consideration at an annual meeting thereof to be held within seventy-five (75) days after such receipt and such
determination is made thereat, or (B) a special meeting of stockholders is called within fifteen (15) days after such receipt for the purpose of making such determination, such meeting is held for such purpose within sixty (60) days
after having been so called and such determination is made thereat. 
 (g) Indemnitee shall cooperate with the Person making such
determination with respect to Indemnitee’s entitlement to indemnification, including providing to such Person upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and
which is reasonably available to Indemnitee and reasonably necessary to such determination. Any costs or expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the Person making such
determination shall be borne by the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby indemnifies and agrees to hold Indemnitee harmless therefrom. 

(h) The Company acknowledges that a settlement or other disposition short of final judgment may be successful if it permits a party to avoid
expense, delay, distraction, disruption and uncertainty. In the event that any action, claim or proceeding to which Indemnitee is a party is resolved in any manner other than by adverse judgment against Indemnitee (including, without limitation,
settlement of such action, claim or proceeding with or without payment of money or other consideration) it shall to the fullest extent permitted by law be presumed that Indemnitee has been successful on the merits or otherwise in such action, suit
or proceeding. Anyone seeking to overcome this presumption shall have the burden of proof and the burden of persuasion by clear and convincing evidence. 

  
 7 

 (i) The termination of any Proceeding or of any claim, issue or matter therein, by judgment,
order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption
that Indemnitee did not act in good faith and in a manner which he reasonably believed to be in or not opposed to the best interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his
conduct was unlawful. 
 7. Remedies of Indemnitee. 

(a) In the event that (i) a determination is made pursuant to Section 6 of this Agreement that Indemnitee is
not entitled to indemnification under this Agreement, (ii) advancement of Expenses is not timely made pursuant to Section 5 of this Agreement, (iii) no determination of entitlement to indemnification is made
pursuant to Section 6(b) of this Agreement within ninety (90) days after receipt by the Company of the request for indemnification or (iv) payment of indemnification is not made within ten (10) days after a
determination has been made that Indemnitee is entitled to indemnification or such determination is deemed to have been made pursuant to Section 6 of this Agreement, Indemnitee shall be entitled to an adjudication in an
appropriate court of the State of Delaware, or in any other court of competent jurisdiction, of Indemnitee’s entitlement to such indemnification, contribution or advancement of Expenses. Alternatively, Indemnitee, at his option, may seek an
award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules of the American Arbitration Association. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in
arbitration. 
 (b) In the event that a determination shall have been made pursuant to Section 6(b) of this
Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 7 shall be conducted in all respects as a de novo trial, or arbitration, on the merits,
and Indemnitee shall not be prejudiced by reason of the adverse determination under Section 6(b). In any judicial proceeding or arbitration commenced pursuant to this Section 7, Indemnitee shall be
presumed to be entitled to indemnification under this Agreement and the Company shall have the burden of proving Indemnitee is not entitled to indemnification or advancement of Expenses, as the case may be, and the Company may not refer to or
introduce into evidence any determination pursuant to Section 6(b) of this Agreement adverse to Indemnitee for any purpose other than to establish its compliance with the terms of this Agreement. If Indemnitee commences a
judicial proceeding or arbitration pursuant to this Section 7, Indemnitee shall not be required to reimburse the Company for any advances pursuant to Section 5 until a final determination is made
with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed). 
 (c)
If a determination shall have been made pursuant to Section 6(b) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration
commenced pursuant to this Section 7, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s misstatement not materially misleading, in
connection with the application for indemnification, or (ii) a prohibition of such indemnification under applicable law. 

  
 8 

 (d) In the event that Indemnitee, pursuant to this Section 7, incurs
costs, in a judicial or arbitration proceeding or otherwise, attempting to enforce his rights under, or to recover damages for breach of, this Agreement, or to recover under any directors’ and officers’ liability insurance policies
maintained by the Company, the Company shall pay on his behalf, in advance, any and all expenses (of the types described in the definition of Expenses in Section 12 of this Agreement) actually and reasonably incurred by him
in such efforts, regardless of whether Indemnitee ultimately is determined to be entitled to such indemnification, advancement of expenses or insurance recovery, to the fullest extent permitted by applicable law. It is the intent of the Company
that, to the fullest extent permitted by applicable law, Indemnitee not be required to incur legal fees or other Expenses associated with the interpretation, enforcement or defense of Indemnitee’s rights under this Agreement by litigation or
otherwise because the cost and expense thereof would substantially detract from the benefits intended to be extended to Indemnitee hereunder. 

(e) The Company shall, to the fullest extent not prohibited by law, be precluded from asserting in any judicial proceeding or arbitration
commenced pursuant to this Section 7 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is
bound by all the provisions of this Agreement. 
 (f) Notwithstanding anything in this Agreement to the contrary, no determination as to
entitlement to indemnification under this Agreement shall be required to be made prior to the final disposition of the Proceeding. 
 8. Non-Exclusivity; Survival of Rights; [Primacy of Indemnification;] Insurance; Subrogation. 
 (a) The
rights of indemnification and to receive advancement of Expenses as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Certificate of Incorporation
of the Company (as amended or restated, the “Charter”), the Bylaws, any agreement, a vote of stockholders, a resolution of directors or otherwise, of the Company. No amendment, alteration or repeal of this Agreement or of any
provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any action taken or omitted by such Indemnitee in his Corporate Status prior to such amendment, alteration or repeal. To the extent that a change in
the DGCL, whether by statute or judicial decision, permits greater indemnification than would be afforded currently under the Charter, Bylaws and this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement
the greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given
hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy. 

(b) The Company shall, if commercially reasonable, obtain and maintain in effect during the entire period for which the Company is obligated
to indemnify Indemnitee under this Agreement, one or more policies of insurance with reputable insurance companies to provide the directors and officers of the Company with coverage for losses from wrongful acts and omissions and to ensure the
Company’s performance of its indemnification 

  
 9 

 
obligations under this Agreement. Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such officer
or director under such policy or policies. In all such insurance policies, Indemnitee shall be named as an insured in such a manner as to provide Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the
Company’s directors and officers. At the time of the receipt of a notice of a claim pursuant to the terms hereof, the Company shall give prompt notice of the commencement of such proceeding to the insurers in accordance with the procedures set
forth in the respective policies. The Company shall thereafter take all necessary or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such proceeding in accordance with the terms of such
policies. 
 (c) [The Company hereby acknowledges that Indemnitee has certain rights to indemnification, advancement of expenses and/or
insurance provided by GTCR and certain affiliates that, directly or indirectly, (i) are controlled by, (ii) control or (iii) are under common control with, GTCR (collectively, the “Fund Indemnitors”). With respect to
any amounts that are subject to indemnity under this Agreement and also subject to an indemnity obligation owed by Fund Indemnitors, the Company hereby agrees (i) that, as compared the Fund Indemnitors, it is the indemnitor of first resort with
respect to any rights to indemnification provided to Indemnitee herein (i.e., its obligations to Indemnitee are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities
incurred by Indemnitee is secondary), (ii) that it shall be required to advance the full amount of expenses incurred by Indemnitee and shall be liable for the full amount of all Expenses, judgments, penalties, fines and amounts paid in
settlement to the extent legally permitted and as required by the terms of this Agreement and the Charter or Bylaws of the Company (or any other agreement between the Company and Indemnitee), without regard to any rights Indemnitee may have against
the Fund Indemnitors, and (iii) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in respect thereof.
The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of Indemnitee with respect to any claim for which Indemnitee has sought indemnification from the Company shall affect the foregoing and the Fund Indemnitors
shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of Indemnitee against the Company. The Company and Indemnitee agree that the Fund Indemnitors are express third
party beneficiaries of the terms of this Section 8(c).] 
 (d) [Except as provided in
Section 8(c) above,] in the event of any payment under this Agreement, the Company shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee [(other than against the Fund
Indemnitors)], who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. 

(e) [Except as provided in Section 8(c) above,] the Company shall not be liable under this Agreement to make any
payment of amounts otherwise indemnifiable (or for which advancement of Expenses is provided) hereunder if and to the extent that Indemnitee has otherwise actually received such payment under any insurance policy, contract, agreement or otherwise.

  
 10 

 (f) [Except as provided in Section 8(c) above,] the Company’s
obligation to indemnify or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, employee or agent of any other corporation, partnership, joint venture, trust, employee benefit plan or
other enterprise shall be reduced by any amount Indemnitee has actually received as indemnification or advancement of expenses from such other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise. 

9. Exception to Right of Indemnification. Notwithstanding any provision in this Agreement, the Company shall not be obligated under
this Agreement to make any indemnity or advancement of expenses in connection with any claim made against Indemnitee: 
 (a) for which
payment has actually been made to or on behalf of Indemnitee under any insurance policy or other indemnity provision, except with respect to any excess beyond the amount paid under any insurance policy or other indemnity provision; [provided,
that the foregoing shall not affect the rights of Indemnitee or the Fund Indemnitors set forth in Section 8(c) above;] or 

(b) for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the
meaning of Section 16(b) of the Exchange Act (as hereinafter defined), or similar provisions of state statutory law or common law; or 

(c) for reimbursement to the Company of any bonus or other incentive-based or equity-based compensation or of any profits realized by
Indemnitee from the sale of securities of the Company in each case as required under the Exchange Act (including any such reimbursements that arise from an accounting restatement of the Company pursuant to Section 304 of the Sarbanes-Oxley Act
of 2002 (the “Sarbanes-Oxley Act”) or Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act in connection with an accounting restatement of the Company or the payment to the Company of profits arising
from the purchase and sale by Indemnitee of securities in violation of Section 306 of the Sarbanes-Oxley Act); 
 (d) in connection
with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other indemnitees, unless
(i) the Company has joined in or the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation, (ii) the Company provides the indemnification, in its sole discretion, pursuant to the powers vested in the
Company under applicable law, or (iii) the Proceeding is one to enforce Indemnitee’s rights under this Agreement or; 
 (e) any
reimbursement of the Company by Indemnitee of any compensation pursuant to any compensation recoupment or clawback policy adopted by the Board or the compensation committee of the Board, including but not limited to any such policy adopted to comply
with stock exchange listing requirements implementing Section 10D of the Exchange Act. 

  
 11 

 10. Non-Disclosure of Payments. Except as
expressly required by the securities laws of the United States of America, neither party shall disclose any payments under this Agreement unless prior approval of the other party is obtained. If any payment information must be disclosed, the Company
shall afford the Indemnitee an opportunity to review all such disclosures and, if requested, to explain in such statement any mitigating circumstances regarding the events to be reported. 

11. Duration of Agreement. All agreements and obligations of the Company contained herein shall continue until and terminate upon the
later of (i) twenty (20) years after the date that Indemnitee shall have ceased to serve as a director or officer of the Company or a director, officer, trustee, partner, managing member, fiduciary, employee or agent of any other corporation,
partnership, joint venture, trust, employee benefit plan or other enterprise which Indemnitee served at the request of the Company, and (ii) one (1) year after the final termination of any Proceeding (including any rights of appeal thereto) in
respect of which Indemnitee is granted rights of indemnification or advancement of Expenses hereunder and of any Proceeding commenced by Indemnitee pursuant to Section 7 of this Agreement relating thereto (including any
rights of appeal of any Section 7 Proceeding). Termination of this Agreement shall not adversely affect any right or protection hereunder of any Indemnitee in respect of any Proceeding (regardless of when such Proceeding is
first threatened, commenced or completed) arising out of, or related to, any act or omission occurring prior to the time of such termination. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the parties hereto
and their respective successors (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of the Company), assigns, spouses, heirs, executors and personal and
legal representatives. 
 12. Definitions. For purposes of this Agreement: 

(a) “Beneficial Owner” shall have the meaning given to such term in Rule 13d-3 under
the Exchange Act; provided, however, that Beneficial Owner shall exclude any Person otherwise becoming a Beneficial Owner by reason of the stockholders of the Company approving a merger of the Company with another entity. 

(b) “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the
following events: 
 (i) Acquisition of Stock by Third Party. Any Person (as defined below), other than GTCR and its
affiliates and other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company or a corporation owned directly or indirectly by the stockholders of the Company in substantially the same proportions as their
ownership of stock of the Company, is or becomes the Beneficial Owner (as defined above), directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding securities,
unless the change in relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding securities entitled to vote generally in the election of directors; 

  
 12 

 (ii) Change in Board of Directors. During any period of two
(2) consecutive years (not including any period prior to the execution of this Agreement), individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered
into an agreement with the Company to effect a transaction described in Section 12(b)(i), 12(b)(iii) or 12(b)(iv)) whose election by the Board or nomination for election by the Company’s stockholders was
approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the period or whose election or nomination for election was previously so approved,
cease for any reason to constitute at least a majority of the members of the Board; 
 (iii) Corporate Transactions.
The effective date of a merger or consolidation of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior to such merger or consolidation
continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than 50% of the combined voting power of the voting securities of the surviving entity outstanding immediately after
such merger or consolidation and with the power to elect at least a majority of the board of directors or other governing body of such surviving entity; and 

(iv) Liquidation. The approval by the stockholders of the Company of a complete liquidation of the Company or an
agreement or series of agreements for the sale or disposition by the Company of all or substantially all of the Company’s assets, or, if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or
disposition in one transaction or a series of related transactions. 
 (c) “Corporate Status” describes the status of a
person who is or was a director, officer, employee, agent or fiduciary of the Company, any direct or indirect subsidiary of the Company, or of any other corporation, partnership, joint venture, trust, employee benefit plan or other enterprise that
such person is or was serving at the express written request of the Company. 
 (d) “Disinterested Director” means a
director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by Indemnitee. 

(e) “Enterprise” shall mean the Company and any other corporation, partnership, joint venture, trust, employee benefit plan
or other enterprise that Indemnitee is or was serving at the request of the Company as a director, officer, trustee, partner, managing member, employee, agent or fiduciary. 

  
 13 

 (f) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

 (g) “Expenses” shall include all reasonable attorneys’ fees, retainers, court costs, transcript costs, fees of
experts and other professionals, witness fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, ERISA excise taxes and penalties, and all other disbursements or expenses of the types
customarily incurred in connection with prosecuting, defending, preparing to prosecute or defend, investigating, participating, or being or preparing to be a witness in a Proceeding, or responding to, or objecting to, a request to provide discovery
in any Proceeding. Expenses also shall include Expenses incurred in connection with any appeal resulting from any Proceeding and any federal, state, local or foreign taxes imposed on Indemnitee as a result of the actual or deemed receipt of any
payments under this Agreement, including without limitation the premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in
settlement by Indemnitee or the amount of judgments or fines against Indemnitee. 
 (h) “Independent Counsel” means a law
firm, or a member of a law firm, that is experienced in matters of corporation law and neither presently is, nor in the past five (5) years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either
such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements), or (ii) any other party to the Proceeding giving rise to a claim for indemnification
hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any Person who, under the applicable standards of professional conduct then prevailing, would have a conflict of interest in representing either the
Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement. The Company agrees to pay the reasonable fees and disbursements of the Independent Counsel referred to above and to fully indemnify such counsel against
any and all Expenses, claims, liabilities and damages arising out of or relating to this Agreement or its engagement pursuant hereto. 

(i) “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act; provided,
however, that Person shall exclude (i) the Company, (ii) any trustee or other fiduciary holding securities under an employee benefit plan of the Company, and (iii) any corporation owned, directly or indirectly, by the
stockholders of the Company in substantially the same proportions as their ownership of stock of the Company. 
 (j)
“Proceeding” includes any threatened, pending or completed action, suit, claim, counterclaim, cross claim, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other
actual, threatened or completed proceeding, whether brought by or in the right of the Company or otherwise and whether civil, criminal, administrative or investigative, in which Indemnitee was, is or will be involved as a party or otherwise, by
reason of the fact that Indemnitee is or was an officer or director of the Company, by reason of any action taken by him or of any inaction on his part while acting as an officer or director of the Company, or by reason of the fact that he is or was
serving at the request of the Company as a director, officer, employee, agent or fiduciary of another corporation, partnership, joint venture, trust or other enterprise; in each case whether or not he is acting or serving in any such capacity at the
time any liability or expense is incurred for which indemnification can be provided under this Agreement; including one pending on or before the date of this Agreement, but excluding one initiated by an Indemnitee pursuant to
Section 7 of this Agreement to enforce his rights under this Agreement. 

  
 14 

 13. Severability. If any provision or provisions of this Agreement shall be held to be
invalid, illegal or unenforceable for any reason whatsoever: (i) the validity, legality, and enforceability of the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this
Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent
permitted by law; (ii) such provision or provisions shall be deemed reformed to the fullest extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and (iii) to the fullest extent
possible, the provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid,
illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby. Without limiting the generality of the foregoing, this Agreement is intended to confer upon Indemnitee indemnification rights to the fullest extent
permitted by applicable laws. 
 14. Enforcement and Binding Effect. 

(a) The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in
order to induce Indemnitee to serve as a director or officer of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving or continuing to serve as a director or officer of the Company. 

(b) Without limiting any of the rights of Indemnitee under the Charter or Bylaws of the Company as they may be amended from time to time,
this Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the
subject matter hereof. 
 (c) The indemnification and advancement of expenses provided by, or granted pursuant to, this Agreement shall be
binding upon and be enforceable by the parties hereto and their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business or assets of
the Company), shall continue as to an Indemnitee who has ceased to be a director, officer, employee or agent of the Company or of any other Enterprise at the Company’s request, and shall inure to the benefit of Indemnitee and his spouse,
assigns, heirs, devisees, executors and administrators and other legal representatives. 
 (d) The Company shall require and cause any
successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Company to expressly assume and agree to perform this Agreement in the same manner and to the
same extent that the Company would be required to perform if no such succession had taken place. 

  
 15 

 (e) The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement,
at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may enforce this Agreement by seeking
injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining
any other relief to which he may be entitled. The Company and Indemnitee further agree that Indemnitee shall be entitled to such specific performance and injunctive relief, including temporary restraining orders, preliminary injunctions and
permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee by the court, and the Company
hereby waives any such requirement of such a bond or undertaking. 
 15. Modification and Waiver. No supplement, modification,
termination or amendment of this Agreement shall be binding unless executed in writing by both of the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions hereof
(whether or not similar) nor shall such waiver constitute a continuing waiver. 
 16. Notice By Indemnitee. Indemnitee agrees
promptly to notify the Company in writing upon being served with or otherwise receiving any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding or matter which may be subject to
indemnification or advancement of Expenses covered hereunder. The failure to so notify the Company shall not relieve the Company of any obligation which it may have to Indemnitee under this Agreement or otherwise unless and only to the extent that
such failure or delay materially prejudices the Company. 
 17. Notices. All notices and other communications given or made pursuant
to this Agreement shall be in writing and shall be deemed effectively given: (i) upon personal delivery to the party to be notified, (ii) when sent by confirmed electronic mail or facsimile if sent during normal business hours of the
recipient, and if not so confirmed, then on the next business day, (iii) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (iv) one (1) day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent: 
  

	 	(a)	 To Indemnitee at the address set forth below Indemnitee’s signature hereto. 

 

	 	(b)	 To the Company at: 

Maravai LifeSciences Holdings, Inc. 

10770 Wateridge Circle, Suite 200 

San Diego, CA 92121 
 Attention:
General Counsel 
 E-mail: 

  
 16 

 or to such other address as may have been furnished to Indemnitee by the Company or to the Company by Indemnitee,
as the case may be. 
 18. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original, but all of which together shall constitute one and the same Agreement. This Agreement may also be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. 
 19. Headings. The headings of the paragraphs of this Agreement are inserted
for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof. 
 20. Usage of
Pronouns. Use of the masculine pronoun shall be deemed to include usage of the feminine pronoun where appropriate. 
 21. Governing
Law and Consent to Jurisdiction. This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict-of-laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section 7 of this Agreement, the Company and
Indemnitee hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of or in connection with this Agreement shall be brought only in the Chancery Court of the State of Delaware (the “Delaware
Court”), and not in any other state or federal court in the United States of America or any court in any other country, (ii) consent to submit to the exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding
arising out of or in connection with this Agreement. 
 [The Remainder of This Page Is Intentionally Left Blank.] 

  
 17 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement on and as of the day
and year first written above. 
  

			
	MARAVAI LIFESCIENCES HOLDINGS, INC.

 
			
		
	By:	 	 

 
			
	Name:	 	
	Title:	 	

  

			
	INDEMNITEE

 
	
	
	 
	Name:
	
	Address:
	
	 
	
	 
	
	 
	
	 

  
 [Signature Page to
Indemnification Agreement]EX-10.26

 Exhibit 10.26 

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM
TO THE REGISTRANT IF PUBLICLY DISCLOSED. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED. 
 SUPPLY AGREEMENT 

This SUPPLY AGREEMENT (this “Agreement”), is made as of October 9, 2020 (the “Effective Date”), by
and among Pfizer Inc., a Delaware corporation, having an address of 235 East 42nd Street, New York, New York 10017 (“Pfizer”), BioNTech SE, a company organized and existing under the laws of Germany, having an address of An der
Goldgrube 12, 55131 Mainz, Germany (“BioNTech”) (each of Pfizer and BioNTech, a “Customer Party,” and collectively, “Customer”) and TriLink BioTechnologies, LLC, a Delaware limited liability
company, having an address of 10770 Wateridge Circle, Suite 200, San Diego, CA 92121 (“Supplier”). Customer and Supplier may be referred to herein individually as a “Party” or collectively as the
“Parties”. 
 WHEREAS, Customer desires to obtain a supply of Product (as defined below) and Supplier desires to provide Customer with such
Product, in accordance with the terms and conditions set forth in this Agreement; 
 NOW, THEREFORE, in consideration of the promises and mutual covenants
expressed herein, and intending to be legally bound thereby, the Parties hereby agree as follows: 
 1. DEFINITIONS 

Terms defined in the preamble of and elsewhere in this Agreement have the meanings set forth therein, and the following terms have the meanings set forth
below: 
 1.1 “Act” means the U.S. Federal Food, Drug and Cosmetic Act, as amended. 

1.2 “Affiliate(s)” means, with respect to each Party, as of any point in time and for so long as such relationship
continues to exist, any corporation, firm, partnership or other entity or person which directly or indirectly controls or is controlled by or is under common control with that Party. For purposes of this definition, “control” (including,
with correlative meaning, the terms “controlled by” and “under common control with”) shall be presumed to exist if one of the following conditions is met: (a) in the case of corporate entities, direct or indirect ownership
of more than 50% of the stock or shares having the right to vote for the election of directors of such Party or any direct or indirect parent of such Party, and (b) in the case of non-corporate entities,
direct or indirect ownership of more than 50% of the equity interest with the power to direct the management and policies of such non-corporate entities. 

1.3 “Business Continuity Management” means a management and governance process supported by Supplier’s senior
management and resourced to ensure identification risks of disruption to its supply of product or service, maintenance of viable recovery strategies and plans, and continuity of products/services. 

1.4 “Business Day” means a day other than a Saturday, Sunday, or a day on which banking institutions in the State of
New York and/or the State of Rhineland-Palatinate are authorized or obligated by law or executive order to close, or as otherwise agreed by the Parties. 

1.5 “CleanCap Reagent” means a chemical manufactured by Supplier for the
co-transcriptional capping of mRNA, as further described in Schedule 1.28. 

  
 1 

 1.6 “CleanCap mRNA” means an mRNA incorporating CleanCap
Reagent. 
 1.7 “Confidential Information” means all information disclosed to a Party or its Personnel by or on behalf of
the other Party or learned or observed by such Party or its Personnel relating to (i) such other Party’s business or business plans, including, but not limited to, suppliers, customers, prospective customers, contractors, manufacturing,
processes, clinical data, the content and format of various clinical and medical databases, utilization data, cost and pricing data, disease management data, software products, programming techniques, data warehouse and methodologies, all
proprietary information, know-how, trade secrets, technical and non-technical materials, products, specifications, processes, sales and marketing plans and strategies,
designs, (ii) information of any third parties for which the disclosing Party or its Affiliates have an obligation of confidentiality, (iii) any discussions and proceedings relating to any of the foregoing information, whether disclosed in
oral, electronic, visual, written or any other form, and (iv) any information developed or derived by a Party from the information of the other Party described in the foregoing clauses (i) – (iii), whether or not for or on behalf of such
Party. Confidential Information includes, without limitation, the terms and conditions of this Agreement. The fact that a Party may have marked or identified as confidential or proprietary any specific information shall be indicative that such Party
believes such information to be confidential or proprietary, but the failure to so mark information shall not conclusively determine that such information is or is not considered confidential information by the disclosing Party. 

1.8 “COVID-19” means
SARS-CoV-2 or COVID-19, and any evolutions or mutations thereof or related or associated epidemics, pandemics or
disease outbreaks. 
 1.9 “Customer Products” means any products manufactured by or on behalf of Customer using Product.

 1.10 “Disclosing Party” means a Party disclosing Confidential Information to the other Party hereunder. 

1.11 “Environmental Laws” means all Laws or other legal requirements of any kind, whether currently in existence or hereafter
promulgated, enacted, adopted or amended, relating to (i) safety (including occupational health and safety); (ii) pollution, conservation, preservation or protection of human health, drinking water, natural resources, biota and the environment;
(iii) the introduction of any chemical substances, products or finished articles into the stream of commerce; (iv) the imposition of any discharge levy or other economic instrument to prevent or reduce discharge or Release of pollutants or
Hazardous Materials; (v) the conduct of environmental impact assessment in connection with the design, development and operation of any facility or project; (vi) the notification, classification, registrations and labeling of new chemical
substances; and/or (vii) the generation, use, storage, handling, treatment, transportation or disposal of Waste including without limitation any matters related to Releases or threatened Releases of Hazardous Materials. 

1.12 “Environmental Losses” means any and all fines, penalties, costs, liabilities, damages or losses incurred by Customer,
or for which Customer is liable or obligated pursuant to or in connection with any Environmental Law or Release or threatened Release of Hazardous Materials (i) arising out of the operation or ownership of the facilities of Supplier, the
facilities of any Affiliate of Supplier, or the facilities of any subcontractor of Supplier or such subcontractor’s Affiliates or (ii) relating to, arising from, or in any way connected with, the testing, manufacture, packaging,
generation, processing, storage, transportation, distribution, treatment, disposal or other handling of Product or materials used in the manufacture, packaging, handling or storage of Product, or associated
by-products, raw materials, intermediates, Wastes or returned Product, in each case by Supplier, Affiliates of Supplier, or subcontractors of Supplier or such subcontractor’s Affiliates, or their
respective officers, directors, employees, agents or contractors. 

  
 2 

 1.13 “Exempt Information” means any information which a Party can demonstrate:
(a) was lawfully in its possession and reduced to writing prior to the time of disclosure by or on behalf of the other Party and which is not subject to another obligation of confidentiality; (b) is or becomes generally available to the
public through no breach of this Agreement by such Party or its Personnel; (c) is obtained from a third party lawfully entitled to possession of such Confidential Information and under no obligation of confidentiality to the other Party or its
Affiliates; or (d) was independently developed by or for such Party without reference to, aid from or reliance upon the Confidential Information of the other Party. 

1.14 “Ex-Im Laws” means the Export Administration Regulations (“EAR”), the International Traffic in Arms
Regulations (“ITAR”), the customs and import laws administered by U.S. Customs and Border Protection, and the EU Dual Use Regulation. 

1.15 “FCPA” means the Foreign Corrupt Practices Act of 1977, as amended. 

1.16 “Global Trade Control Laws” means, collectively, Ex-Im Laws and Sanctions Laws. 

1.17 “Government” means all levels and subdivisions of governments (i.e., local, regional, or national and administrative,
legislative, or executive). 
 1.18 “Government Official” means: (i) any elected or appointed non-U.S. Government official (e.g., a legislator or a member of a non-U.S. Government ministry); (ii) any employee or individual acting for or on behalf of a non-U.S. Government official, non-U.S. Government agency, or enterprise performing a function of, or owned or controlled by, a non-U.S.
Government (e.g., a healthcare professional employed by a non-U.S. Government hospital or researcher employed by a non-U.S. Government university); (iii) any non-U.S. political party officer, candidate for non-U.S. public office, or employee or individual acting for or on behalf of a non-U.S.
political party or candidate for public office; (iv) any employee or individual acting for or on behalf of a public international organization; (v) any member of a royal family or a member of a
non-U.S. military, and (vi) any individual otherwise categorized as a Government Official under Law. 

1.19 “Governmental Authority” means any court, tribunal, or arbitral body with competent jurisdiction; any military,
quasi-military, or law enforcement agency; or any other entity agency, department, authority, or other instrumentality of any supra-national, federal, national, state, county, local, municipal, other political subdivision, administrative authority,
agency, commission, instrumentality, or other governmental, regulatory body. 
 1.20 “Hazardous Materials” means any and
all materials (including without limitation substances, chemicals compounds, mixtures, products, byproducts, biologic agents, living or genetically modified materials, wastes, pollutants and contaminants), that (A) (i) are listed, classified,
characterized or regulated pursuant to Environmental Laws; (ii) are identified, defined, or classified as “hazardous”, “dangerous”, “toxic”, “pollutant”, “contaminant”, “waste”,
“irritant”, “corrosive”, “flammable”, “radioactive”, “reactive”, “carcinogenic”, “mutagenic”, “bioaccumulative”, or “persistent” in the environment; or
(iii) harm, endanger or cause injury to human health, natural resources or the environment; or (B) petroleum products and their derivatives, asbestos-containing material, lead-based paint, polychlorinated biphenyls, urea formaldehyde, or
viral, bacterial or fungal material. 

  
 3 

 1.21 “Intellectual Property” means (a) any processes, trade secrets,
inventions, industrial models, designs, methodologies, drawings, formulae, procedures, techniques, clinical data or technical or other information or data, manufacturing, engineering and technical drawings necessary or useful in the registration,
packaging, manufacture, use or sale of the Product, and (b) registered trademarks, trade mark applications, supplementary protection certificates, petty patents, utility models, trade names, trade dress, logos, database rights, rights in
designs, copyrights and topography rights (whether or not any of these rights are registered, and including applications and the right to apply for registration of any such rights) and all inventions, unregistered marks, trade dress, copyrights, know-how, patents, patent applications, and any and all provisionals, divisions, continuations, continuations in part, extensions, substitutions, renewals, registrations, revalidations, reissues or additions,
including supplementary certificates of protection, of or to any of the aforesaid patents and patent applications, and all foreign counterparts of any, or to any, of the aforesaid patents and patent applications, or any future patents or patent
applications covering the Product or any components thereof or improvements thereof. 
 1.22 “Latent Defect” means any non-conformity in the Product or portion of the Product which was not identified through the application of the quality review and testing processes set forth in the Quality Agreement and which could not have been
reasonably identified by Customer’s quality assurance Personnel at the time of receipt. 
 1.23 “Laws” means,
collectively, all applicable international, supranational, national, federal, state, provincial, regional and local laws, statutes, ordinances, codes, rules, regulations, orders, decrees or other pronouncements of any governmental, administrative or
judicial authority having the effect of law, including Environmental Laws and Global Trade Control Laws. 
 1.24 “Licensed Patent
Rights” refer to Supplier’s U.S. Patent 10,519,189 and U.S. Patent 10,494,399, including all foreign counterparts of the foregoing including all substitutions, extensions, reexaminations, reissues, renewals, divisionals, continuations
or continuations-in-part therefore and all patents issuing therefrom. 

1.25 “Licensee Products” shall mean any substance, compound or product that (a) is designed or developed by or on behalf
of Customer or any of its Affiliates, (b) contains CleanCap mRNA, and (c) is intended to be used for any research purpose, development purpose, commercial purpose, therapeutic purpose, or in a clinical trial. 

1.26 “Losses” means any and all damages, fines, fees, settlements, payments, obligations, penalties, deficiencies, losses,
costs and expenses (including Environmental Losses, interest, court costs, reasonable fees of attorneys, accountants and other experts and other reasonable expenses of litigation or other proceedings or of any claim, default or assessment) of any
kind and character, known or unknown, foreseeable, contingent or liquidated, whether now or existing hereafter. 
 1.27
“Personnel” means all Affiliates, subcontractors, or other third parties, and employees and agents of each of them, used by Supplier in the performance hereunder. 

1.28 “Price Approval” means, in any country where a Governmental Authority authorizes reimbursement for, or approves or
determines pricing for, pharmaceutical products, receipt (or, if required to make such authorization, approval or determination effective, publication) of such reimbursement authorization or pricing approval or determination (as the case may be).

  
 4 

 1.29 “Product” means products set out in Schedule 1.28 that are to be
manufactured and supplied by Supplier or Supplier’s Affiliate to Customer under this Agreement. Additional Products may be added from time to time by written agreement between the Parties. 

1.30 “Quality Agreement” means that certain Quality Agreement dated as of the Effective Date entered into by and between
Customer and Supplier, in the form attached hereto as Schedule 4.9. 
 1.31 “Receiving Party” means a Party receiving
Confidential Information from the other Party hereunder. 
 1.32 “Records” means any books, documents, accounting
procedures and practices and other data, regardless of type or form, of all matters relating to Supplier’s performance of its obligations under this Agreement that enable Supplier to demonstrate compliance with such obligations, including,
without limitation, Supplier’s compliance with Laws. 
 1.33 “Regulatory Approval” means all technical, medical and
scientific licenses, registrations, authorizations and approvals (including approvals of NDAs, supplements and amendments, pre- and post- approvals and labeling approvals) of any Regulatory Authority,
necessary or useful for the use, development, manufacture, and commercialization of a Customer Product in a regulatory jurisdiction, including commercially reasonable Price Approvals and commercially reasonable Third Party reimbursement approvals.

 1.34 “Regulatory Authority” means, with respect to a country in the Territory, any national (e.g., the FDA),
supra-national (e.g., the European Commission, the Council of the European Union, or the European Medicines Agency), regional, state or local regulatory agency, department, bureau, commission, council or other Governmental Authority involved in the
granting of a Regulatory Approval or, to the extent required in such country, Price Approval, for pharmaceutical products in such country. 

1.35 “Release” means the release, spill, emission, leaking, pumping, pouring, emptying, escaping, dumping, injection,
deposit, disposal, discharge, dispersal, leaching or migration into the indoor or outdoor environment, including the uncontrolled presence or the movement of Hazardous Materials through the ambient air, soil, subsurface water, groundwater, wetlands,
lands or subsurface strata or threat thereof. 
 1.36 “Restricted Market(s)” for purposes of this Agreement means any
country or region subject to sanctions by the United States and the European Union. 
 1.37 “Restricted Party(ies)” for
purposes of this Agreement means the means an individual or entity on the list of sanctioned entities maintained by the United Nations Security Council; the Specially Designated Nationals List and the Sectoral Sanctions Identifications List of the
U.S. Treasury Department’s Office of Foreign Assets Control; the U.S. Denied Persons List, the U.S. Entity List, and the U.S. Unverified List of the U.S. Department of Commerce; the Consolidated List of Persons, Groups and Entities Subject to
E.U. Financial Sanctions, as implemented by the E.U. Common Foreign and Security Policy; the List of Excluded Individuals / Entities published by the U.S. Health and Human Services Office of Inspector General; any lists of prohibited or debarred
parties established under the U.S. Federal Food Drug and Cosmetic Act; and the list of parties suspended or debarred from contracting with the U.S. government. 

1.38 “Sanctions Laws” means Laws relating to economic or trade sanctions administered or enforced by the United States
(including by the U.S. Department of the Treasury, Office of Foreign Assets Control or the U.S. Department of State), the United Nations Security Council, and the European Union. 

  
 5 

 1.39 “Specifications” means the specifications set out in the Product Schedule
(Schedule 1.24). Specifications may be updated from time to time by written agreement between the Parties. 
 1.40
“Territory” means worldwide. 
 1.41 “Transparency Laws” means, collectively, those laws, implementing
regulations, and industry codes, including without limitation section 6002 of the U.S. Affordable Care Act and the EFPIA Code on Disclosure of Transfers of Value, that require Customer to report payments or other transfers of value to certain
healthcare professionals and teaching hospitals. 
 1.42 “Waste” means all wastes which arise from the manufacture,
handling or storage of Product hereunder, or which is otherwise produced through the operations of Supplier or its Personnel through implementation of this Agreement including Hazardous Materials. 

2. SUPPLY OF PRODUCT AND SCOPE OF SERVICES 

2.1 Customer and its Affiliates. During the Term, Supplier shall supply Product to Customer and/or its Affiliate(s) pursuant to the
terms of this Agreement, as ordered by each Customer Party and/or its Affiliate(s) pursuant to Section 2.5. Supplier agrees to provide the Product to Customer and such Affiliate(s) of Customer pursuant to Orders issued by each Customer Party or
such Affiliate(s). Any such Affiliate that issues an Order to Supplier pursuant to this Agreement shall be entitled to all of the rights and benefits afforded to Customer, and the obligations and duties imposed on Customer, in each case as set forth
hereunder (provided that any enforcement of this Agreement with respect to an Affiliate shall be conducted through Customer only), and references to “Customer” in this Agreement shall be deemed to include such Affiliate(s) with respect to
such Orders and, as applicable, other obligations hereunder. Customer shall be responsible for all liabilities of any such Affiliates and the compliance of such Affiliates with the terms and conditions of this Agreement (as if each such Affiliate is
a party to this Agreement in the place of Customer in connection with any Order such Affiliate it makes). Supplier shall have liability to Customer for any breaches of this Agreement affecting Orders of such Affiliates, but no such Affiliate may
bring any action hereunder directly against Supplier. 
 2.2 Non-exclusivity. Product under
this Agreement shall be provided on a non-exclusive basis and Customer reserves the right to purchase substitute or equivalent products from any other person or entity. Except as explicitly set forth in
Section 2.6, Customer is not obligated to purchase any minimum or specific quantity, volume or dollar amount of Product hereunder. 

2.3 Dual Sourcing. Supplier shall identify a third party manufacturer by [***] which can serve as a second qualified source of Product
and shall make commercially reasonable efforts thereafter to implement a second source of Product, including without limitation subcontracting production to third party contract manufacturers and building new facilities (“Second Source”).
Supplier shall provide quarterly updates on Supplier’s progress and promptly inform the Customer of any delays in progress. 
 2.4
Hierarchy of Terms. In the event that there are any conflicts between the terms of this Agreement and the terms of any Order, the terms of this Agreement shall control. The terms of this Agreement and the Order shall be controlling over any
terms of any Order, sales acknowledgement, invoice or other such documents issued by either Party. 

  
 6 

 2.5 Forecasts and Orders 

(a) Forecasts. 
  

	 	(i)	 On or before the Effective Date and continuing through July 2021, Customer shall forecast and order Product in
accordance with Schedule 2.5(a)(i). 

  

	 	(ii)	 On or before the fifth (5th) Business Day of July 2021 and
thereafter monthly for the remainder of the Term, Customer shall submit to Supplier a good faith, estimated rolling forecast of the quantity of Products (on a per SKU basis) that it expects to order for each of the succeeding twelve
(12) calendar months following the month in which the forecast is submitted (each such forecast, a “Forecast”). Such Forecasts represent Customer’s reasonable estimates of the quantity of Product it may require at the time
such Forecast is made, during the applicable twelve (12) month period. Each Forecast shall be firm and binding (a “Firm Order”) for the first [***] months set forth on the applicable Forecast and as further set forth below.
Commencing with the second Forecast, months [***] through [***] of the immediately preceding Forecast may be adjusted up or down by no more than [***] above or below the quantities indicated in such preceding Forecast (such that at least [***] of
the original Forecast quantities for months [***] through [***] shall be a Firm Order) and months [***] through [***] of the preceding Forecast are non-binding and may be adjusted up or down as required by
Customer. The Parties shall meet monthly to discuss in good faith whether adjustments to Firm Orders are required. Notwithstanding the foregoing, in no event shall Supplier be required to supply any quantity of Product in any given period that
exceeds [***] of Supplier’s aggregate production capacity over such period. 

 (b) Orders. Supplier shall
provide Product to each Customer Party pursuant to purchase orders issued by a Customer Party to Supplier (each an “Order”). Such Orders shall be in the form of a written or electronic Order form and each Customer Party shall submit
such Orders to Supplier at a frequency that is, at maximum, once per month, and, without limiting each Customer Party’s obligations to meet its Firm Order commitments, each Customer Party shall use commercially reasonable efforts to cover all
Products included in the applicable Firm Order for the period the Order covers. No verbal communications or e-mail shall be deemed to be an Order or construed to be a commitment to purchase. Supplier shall
provide to each Customer Party such quantities of Product as may be ordered by each Customer Party pursuant to such Orders to the extent consistent with Forecast, and Supplier will use commercially reasonable efforts to accommodate Orders that are
in excess of the Forecast amounts constituting Firm Orders (“Additional Quantities”). Supplier’s inability to supply amounts greater than the binding Forecast amount shall not constitute breach of any term herein. In the event
that Supplier cannot meet the part of the Forecast attributable to either Customer Party, Supplier shall supply Products to the Customer Parties in the same proportion that was supplied to each under the most recent Forecast prior to such shortfall
(hereinafter referred to as the “Proportionate Supply Instruction”). In the event that a Customer Party orders Additional Quantities, Supplier shall use its commercially reasonable efforts to meet such Customer Party’s
requested delivery dates for such Additional Quantities as set forth in the applicable Order. For purposes of this paragraph, the most recent Forecast for any given month shall mean the Forecast submitted by a Customer Party [***] months prior to
the month in which the applicable Order is issued. 

  
 7 

 2.6 Modification/Cancellation of Orders. Any modifications or cancellations to any Order
shall be made only by mutual agreement of the Parties and in no event shall relieve Customer of its obligation to make payment for all quantities of Product included in a Firm Order. 

2.7 Delivery and Shipping 

(a) Shipping. Supplier shall ship Product ordered by Customer to the ship-to destination set
forth in the applicable Order, in accordance with reasonable shipping instructions as may be provided to Supplier by Customer. In the event that Customer designates the carrier, Supplier shall deliver Product to Customer Ex Works Supplier’s
facility (Incoterms 2020) and work cooperatively with any carrier selected by Customer. Supplier shall provide a complementary service for the transfer of Product to carrier in-person, and Product shall not be
left unattended at Supplier’s premises during carrier pick-up. 
 (b) Certificates of
Release. Supplier shall include certificates of release and certificates of analysis with all shipments of Product. 
 (c) Title.
Title to Product and risk of loss or damage shall pass to Customer when the Product has been made available to Customer’s carrier at Supplier location pursuant to Section 2.7(a). 

(d) Timely Delivery. All dates for delivery of Product are firm and time is of the essence. 

(e) Delivery Dates. Supplier shall deliver Product to Customer’s address as specified in the applicable Order by or within the
delivery date(s) specified in the applicable Order, or such other date as may be agreed to in writing by the Parties from time to time (the “Delivery Date”). Supplier acknowledges and agrees that untimely delivery of the Product,
including early or late delivery, may constitute Non-conforming Product under Section 4.1. 

2.8 Delivery Performance Reporting. If requested by Customer or a Customer Party, Supplier shall monitor and report no more than
quarterly, or as part of any applicable business review, its performance in meeting Customer’s required Delivery Dates and other performance data. Such reports shall be submitted to the appropriate Customer representative as identified by
Customer from time to time, in a format reasonably acceptable to Customer. 
 2.9 Alternative Supply.  

(a) Subject to the terms and conditions set forth in Article 8 and without granting or implying any license to Supplier’s Intellectual
Property (or limiting Supplier’s enforcement rights with respect to the same), nothing in this Agreement shall prevent Customer from manufacturing for itself a product similar to the Product, or having such similar product manufactured by a
third party or procuring such product from a third party. 
 (b) In the event that at any time during the Term Supplier is, or anticipates
it (including any Second Source) shall be, unable or unwilling at any time to supply any Product ordered by Customer in accordance with the then applicable Forecast (such event a “Non-Delivery
Event”): 
 (i) Supplier shall supply to Customer the same proportion of total Product produced for all customers that is consistent
with the proportion of total output supplied to Customer prior to any shortfall; and 

  
 8 

 (ii) By March 31, 2021, Supplier shall establish and maintain as safety stock [***] months
of supply for the intermediates listed in Schedule 2.9(b)(ii) (“Safety Stock”). The volume of Safety Stock will initially be based on the Forecast for the first quarter of 2021 and will be adjusted by the Parties as needed in accordance
with Customer’s subsequent quarterly requirements. The Safety Stock shall serve as part of the business continuity plan. Supplier shall maintain the agreed Safety Stock level at all times and provide report to Customer during Quarterly Business
Reviews; and 
 (iii) Supplier shall in good faith notify Customer within five (5) Business Days upon Supplier becoming aware of such Non-Delivery Event and, if required, Supplier shall meet with Customer within two (2) weeks after such notification to discuss in good faith options to resolve the inability to supply and to minimize the impact
of the inability to supply to Customer. Supplier shall cooperate with Customer in taking all actions that Supplier and Customer deem reasonable to remedy such inability to supply. In the event that, Customer and Supplier fail to agree to mutually
acceptable terms and conditions of the manner in which to provide Customer with an alternative supply of Product within thirty (30) days of commencing discussions (the “End Date”) (such consent not to be unreasonably
conditioned, withheld, or delayed) then Customer shall have the right at Customer’s option: (A) to cancel, without penalty, all Orders affected by such inability to supply; or (B) for each affected Order, to have a third party
manufacturer manufacture and supply, the portion of Customer’s requirements of Product unable to be supplied by Supplier. To the extent possible, such rights shall be limited to the duration of the
Non-Delivery Event. If Customer determines that a third party manufacturer is required, a pre-qualified third party manufacturer as set forth in Section 2.3, if
any, shall be promptly engaged as a secondary supply source for Product. If there is no pre-qualified third party manufacturer, Customer shall provide Supplier with a list of three (3) potential third
party manufacturers to be engaged as a secondary supply source for Product within [***] days after the End Date. Within [***] business days of such submission by Customer, Supplier shall provide written approval of at least one (1) of the
potential third party manufacturers as a secondary supply source for Product. If Supplier does not provide such written approval within [***] business days of Customer’s proposal, Supplier will be deemed to have granted consent to the
engagement of any of the three (3) potential third party manufacturers proposed by Customer as a secondary supply source for Product. Upon selection of the third party manufacturer, Supplier shall provide reasonable assistance in arranging for
such manufacture, including making technical Personnel reasonably available. Supplier shall provide to the third-party manufacturer, at Supplier’s cost (other than
out-of-pocket costs such as shipping), all Product materials and equipment provided or purchased by Customer and in the possession of Supplier, used in the production of
the Product. Customer shall require any such alternative supplier with access to the know-how to enter into a license and confidentiality agreement directly with Supplier (and Supplier shall enter into such an
agreement with such alternative supplier) with respect any know-how necessary to make the Product, for use solely in connection with Orders to be supplied by such alternative supplier in accordance with the
terms above. 
 3. FEE, PRICE AND PAYMENT 

3.1 Issue Fee. Customer shall pay to Supplier a one-time license issue fee (“Issue
Fee”) of [***] within thirty (30) days after the Effective Date, which shall not be creditable against any amounts due hereunder. 

3.2 Pricing. The price (the “Price”) of Product sold to Customer by Supplier shall be as set forth in the Pricing
Schedule attached hereto as Schedule 3.2 and is made a part hereof. All such Prices shall be firm for the Initial Term, unless otherwise agreed to by the Parties, subject to discounting and other adjustments in accordance with Schedule 3.2. 

  
 9 

 3.3 Cost Reduction. Supplier and Customer agree to mutually cooperate, using their joint
commercially reasonable best efforts, to identify cost reduction opportunities. 
 3.4 Fees. The total fees for any Products provided
to Customer by Supplier shall be set forth in the Order. In no event shall a Customer Party be responsible for any costs beyond the agreed fees as set forth in the applicable Order without the prior written approval of both Parties. 

3.5 Billing. Supplier shall submit invoices to Customer upon completion of milestones as outlined in SCHEDULE 3.2, to the address
designated in the applicable Order. Supplier shall include the following information on all invoices: the applicable Order number and billing address; and shall also include, where applicable, the type, description, part number (if any) and quantity
of the Product delivered; the Delivery Date; the actual date of shipment; the Prices; any applicable taxes, transportation charges or other charges provided for in the applicable Order; and the ship-to
destination. 
 3.6 Payment. Unless Customer notifies Supplier pursuant to Section 4.1 that the Product is non-conforming, Supplier shall invoice Customer upon the earlier of: (i) completion of respective milestone per SCHEDULE 3.2 and/or delivery of the Product to Customer’s carrier in accordance with
Section 2.7(a); and (ii) acceptance of the Product by Customer. Customer shall pay all undisputed amounts due [***] days from the date of Customer’s receipt of the invoice, (“Invoice Due Date”) and payment shall be
made with the next scheduled processing payment run immediately following the Invoice Due Date, and in accordance with the applicable Order. Payment history will be reviewed quarterly and if the average payment time is not within the terms of this
Agreement, the Parties will work together in good faith to modify the payment terms and ensure compliance with this Section. If Customer disputes all or any portion of an invoice, it shall be required to pay only the amount not in dispute. In such
event, Customer shall notify Supplier of the amount and nature of the dispute and the Parties shall attempt to resolve the dispute in good faith in accordance with Section 14.2. Payment by Customer shall not result in a waiver of any of its
rights under this Agreement. Customer may set off any amount Supplier owes Customer against amounts payable under this Agreement or any other agreement between the Parties. 

3.7 Late Delivery. If Supplier fails to timely deliver Product to Customer in accordance with Section 2.7(e) for [***] Business
Days, Supplier shall promptly activate the Second Source to address the delinquency and use intermediate Safety Stock as applicable to help satisfy Customer’s requirements. 

3.8 Taxes. The Prices include all taxes except such sales, use, value-added and similar taxes which Supplier is required by Law to
collect from Customer. Such taxes, if any, will be separately stated in Supplier’s invoice and will be paid by Customer to Supplier unless Customer provides evidence of an exemption to Supplier. Supplier shall be solely responsible for the
timely payment of all such taxes to the applicable taxing authority, and Supplier shall pay (without reimbursement by Customer), and shall hold Customer harmless from and against, any penalties, interest or additional taxes that may be levied or
assessed as a result of the failure or delay of Supplier to pay any such taxes. 
 3.9 Most Favored Nations. It is the intention of
the Parties under this Agreement that the Customer shall have the most favored pricing for Product for commercial mRNA vaccine production throughout the Term. In the event that the Supplier offers or agrees to pricing for the Product with a
third party purchasing the same or greater volumes of Product than Customer that is less than the Prices set forth herein, the Supplier shall promptly, and in no event later than thirty (30) days following its offering or agreeing to such
pricing to a third party, notify the Customer of such reduced pricing and offer such reduced pricing to the Customer. 

  
 10 

 4. QUALITY AND CONFORMANCE 

4.1 Inspection; Rejection of Non-conforming Product. All Product provided by Supplier hereunder
shall be subject to inspection and testing by Customer in accordance with the Quality Agreement. Customer may reject any Product that: (i) fails to conform to the warranties set forth in this Agreement, or (ii) fails to conform to the
Specifications or otherwise fails to conform to the applicable Order. (“Non-conforming Product”) by providing written notice to Supplier within sixty (60) days after receipt of shipment,
provided, however, that Customer may provide of notice of rejection of any Product within sixty (60) days after notification or discovery with respect to any Latent Defects. 

4.2 Refund, Replacement of Non-conforming Product. Customer may return to Supplier at
Supplier’s expense any Product rejected pursuant to Section 4.1. In addition to any other rights or remedies of Customer hereunder, Supplier shall, at Customer’s option: (i) replace any Product rejected by Customer, at no
additional cost to Customer, as soon as reasonably practicable on an expedited basis; or (ii) provide a credit or refund to the applicable Customer Party for the full amount invoiced for such Product, which shall be credited or refunded (as the
case may be) to such Customer Party within thirty (30) days after request. 
 4.3 Change Control. Supplier will comply with the
Quality Agreement as each applies to Change Control. 
 4.4 Practices. Supplier will comply with the Quality Agreement and ISO
9001:2015 as each applies to Supplier’s performance hereunder. 
 4.5 Pest Control. Supplier shall manufacture and store
Product, in accordance with Section F.5 of the Contract Manufacturing Quality Agreement. Failure of Supplier to comply with this Section 4.5 shall be deemed a material breach of this Agreement. 

4.6 Audits. Customer shall have those audit and inspection rights as set forth in the Quality Agreement. 

4.7 Performance Notices 

(a) Supplier shall notify Customer of any known contamination or non-conformity that may impact the
Product within (3) Business Days of receipt by Supplier of notice of same. 
 (b) Supplier shall notify Customer within one
(1) Business Day if Supplier becomes the subject of any regulatory investigations or actions initiated by any governmental, administrative or regulatory agency relating to a Product or to Supplier’s performance or ability to perform under
the Agreement, or receives any initial contact or communication from any governmental, administrative or regulatory agency relating to a Product or to Supplier’s performance or ability to perform under the Agreement. 

4.8 Quality Assurance. Supplier shall have a formal quality assurance program that is in compliance with ISO 9001:2015 and/or the
requirements set forth in the Quality Agreement, as applicable, and appropriate written quality control procedures covering its operations, which shall be made available to Customer upon its request. Supplier shall notify Customer of any
modifications to such program or procedures to the extent such modification may affect the Product or Supplier’s performance of its obligations under this Agreement. Supplier shall comply with such quality assurance program and quality control
procedures at all times in connection with the Supplier’s performance of its obligations under this Agreement. 

  
 11 

 4.9 Quality Agreement. The Parties agree to comply with the requirements and provisions
set forth in the Quality Agreement attached hereto as Schedule 4.9 and made a part hereof. In the event of a conflict between the terms of the Quality Agreement and the terms of this Agreement, the terms of this Agreement shall prevail, except with
respect to quality matters. 
 4.10 Customer Support. Supplier shall provide means for Customer to contact Supplier’s service
representative during Supplier’s operating hours, which shall be at a minimum from 9:00 a.m. to 5:00 p.m. (Pacific Time) five (5) days a week, excluding U.S. holidays, during the Term. 

4.11 Root Cause Analysis. Upon notice by Customer to Supplier that the Product is
Non-conforming Product or of latent defects in the Product, Supplier shall promptly and diligently: (i) investigate and attempt to determine the root cause of such
non-conformance or defect; (ii) undertake corrective action; and (iii) at all times keep Customer promptly informed of such investigation and the progress of such corrective action. If a root cause
is determined, then Supplier shall promptly notify and report the results to Customer, and Supplier and Customer will cooperate in good faith on a corrective action plan. 

4.12 Investigations; Stability Study. If Customer requests additional investigations beyond Supplier’s obligations defined in the
Quality Agreement, Supplier will review and may require a separate scope of work to cover such additional investigations. 
 5. REPRESENTATIONS,
WARRANTIES, AND COVENANTS 
 5.1 Product. Supplier represents, warrants and covenants to Customer that the Product supplied by
Supplier to Customer under this Agreement: (i) shall be manufactured, marked, packaged, labeled, handled, stored, documented for transport and shipped in compliance with all Laws including, as applicable, and ISO 9001:2015 requirements and/or
the requirements of the Quality Agreement; (ii) shall be manufactured, packaged, marked, labeled, handled, stored documented for transport and shipped in accordance with, and shall conform to, the Specifications; (iii) shall not be
adulterated or misbranded within the meaning of Sections 501 and 502, respectively, of the Act and any other Laws; (iv) shall be free from defects in material and workmanship; and (v) shall not knowingly infringe any patent, copyright, or
trademark or misappropriate any trade secret or other Intellectual Property or proprietary rights of any third party. 
 5.2 Title to
Product. Supplier represents, warrants and covenants to Customer that Supplier has good title to all Product supplied to Customer pursuant to this Agreement and shall pass such title to Customer free and clear of any security interests, liens,
or other encumbrances. 
 5.3 Compliance with Laws. Supplier represents, warrants and covenants to Customer that Supplier is in
compliance in all material respects and shall continue to comply in all material respects, and shall procure that its Personnel comply in all material respects, with all Laws, and Supplier has and shall continue to have, and shall procure that its
Personnel have, all professional licenses, consents, authorizations, permits, and certificates, and shall have and shall procure that Supplier’s Personnel have completed all registrations or made such notifications as required by Law for its
performance of this Agreement. Customer is an equal opportunity employer and federal contractor. Consequently, the parties agree that, as applicable, they will abide by the requirements of Executive Order 11246, 41 CFR 60-1.4(a); the Vietnam Era Veterans’ Readjustment Assistance Act, 41 CFR 60-300.5(a); and  

  
 12 

 
Section 503 of the Rehabilitation Act of 1973, 41 CFR 60-741.5(a), and that these laws are incorporated herein by reference. These regulations
prohibit discrimination against qualified individuals based on their status as protected veterans or individuals with disabilities, and prohibit discrimination against all individuals based on their race, color, religion, sex, sexual orientation,
gender identity, or national origin. These regulations require that covered prime contractors and subcontractors take affirmative action to employ and advance in employment individuals without regard to race, color, religion, sex, sexual
orientation, gender identity, national origin, protected veteran status or disability. The parties also agree that, as applicable, they will abide by the requirements of Executive Order 13496 (29 CFR Part 471, Appendix A to Subpart A), relating to
the notice of employee rights under federal labor laws. 
 5.4 Claims and Conditions. Supplier represents and warrants to
Customer that, as of the Effective Date, there is no pending or likely governmental enforcement action or private claim against Supplier, or any environmental conditions, events or circumstances that are reasonably likely to limit, impede or
otherwise jeopardize the Supplier’s ability to meet its obligations under this Agreement. 
 5.5 Debarment. Supplier represents
and warrants to Customer that Supplier is not, and covenants to Customer that during the Term it shall not be, debarred by any applicable Governmental Authority, including without limitation under subsections 306(a) or (b) of the Act, and
Supplier has not and will not use in any capacity in the performance of this Agreement the services of any person or entity who has been debarred by any applicable Governmental Authority. Supplier shall immediately notify Customer in the event that
Supplier or any of its Personnel becomes debarred or excluded during the Term. Notwithstanding the cure period set forth in Section 7.1, Supplier acknowledges that any such debarment shall be grounds for immediate termination of this Agreement
and any or all Orders by Customer for cause. 
 5.6 Compliance with FCPA. Supplier represents and warrants to Customer that in the
past five (5) years Supplier has not, and covenants to Customer that it will not, directly or knowingly indirectly offer or pay, or authorize any offer or payment of, any money or other thing of value to improperly or corruptly seek to
influence any Government Official or any other person in order to gain an improper business advantage, and has not accepted in the past five (5) years, and will not accept in the future, such a payment. 

5.7 Customer Policies. Supplier shall ensure that it and its Personnel comply with all of the policies, regulations and directives of
Customer listed on Schedule 5.7 and incorporated herein. 
 5.8 Environmental, Health & Safety 

(a) Compliance. Supplier represents, warrants and covenants to Customer that Supplier shall perform all of its obligations herein in
compliance with all Environmental Laws and all necessary environmental or other licenses, registrations, notifications, certificates, approvals, authorizations or permits required under Environmental Laws and any private permissions. Supplier shall
abate any condition or practice, regardless of whether such condition or practice constitutes non-compliance with Environmental Laws, which poses a significant threat to human health, safety, or the
environment, or would be reasonably likely to limit, impede, or otherwise jeopardize Supplier’s ability to fulfill its obligations to Customer. 

(b) Environmental Losses. Supplier shall be solely responsible for all Environmental Losses incurred during the performance of this
Agreement. 

  
 13 

 (c) Hazardous Materials and Waste. Supplier shall be solely responsible for the
generation, collection, storage, handling, transportation, movement and disposal of all Hazardous Materials and Waste, as applicable, in compliance with Environmental Laws. Supplier agrees to release Customer from any liability and waive any claim,
pursuant to statute, code, or common law, that Customer is liable to it or to any third party, for any Environmental Loss arising out of the management of Supplier’s Waste. 

(d) Environmental, Health & Safety Information. Supplier shall provide to Customer all information related to
the safety, safe handling, environmental impact, and disposal of the Product including, without limitation, material safety data sheets. Throughout the Term, Supplier shall promptly deliver to Customer, as it becomes available to Supplier, any
updates or amendments to the information provided pursuant to this Section 5.8(d) and any new information relating to the safety, safe handling, environmental impact, or disposal of the Product. 

(e) Notice of Incidents. Supplier shall provide prompt notification to Customer in the event of any significant condition or incident,
which shall include any event, occurrence, or circumstance, including any governmental or private action, which could materially impact Supplier’s ability to fulfill its obligations under this Agreement. These include, but are not limited to:
(i) material revocation or modification of any licenses, registrations, notifications, certificates, approvals, authorizations or permits required by any Law, (ii) any action by Governmental Authorities that may reasonably lead to the
material revocation or modification of Supplier’s required permits, licenses, or authorizations, (iii) above, any third party claim against the management or ownership of the facility that could reasonably impact Supplier’s
obligations under this Agreement, (iv) any fire, explosion, significant accident, or catastrophic Release of Hazardous Substances, or significant “near miss” incident, (v) any significant
non-compliance with Environmental Laws, and (vi) any environmental condition or operating practice that may reasonably be believed to present a significant threat to human health, safety or the
environment. 
 5.9 Responsible Supply Chain 

(a) Supplier represents, warrants, and covenants that it does not, as of the Effective Date, and shall not, during the Term (i) use
involuntary, bonded or underage labor (defined in accordance with Laws and to the extent Laws) at the facility(ies) where its performance under this Agreement will occur; (ii) engage in human trafficking; or (iii) maintain unsafe or
unhealthy conditions in any dormitories or lodging that it provides for its employees. Supplier agrees that during the Term it shall promptly correct unsafe or unhealthy conditions in any dormitories or lodging that it provides for its employees.
disclose to Customer any use, whether intentional or unintentional, of involuntary, bonded or underage labor or instances of human trafficking, and shall correct unsafe or unhealthy conditions in any lodging that it provides for its employees.
Supplier shall use reasonable efforts to include similar prohibition and disclosure requirements in agreements with its own suppliers. Supplier shall cooperate and provide such information and/or certifications as are reasonably necessary if
Customer is obligated to provide or post disclosures regarding labor practices, including, without limitation, disclosures under the California Transparency In Supply Chains Act of 2010, California Civil Code § 1714.43, and similar Laws. 

(b) Supplier covenants that it will perform its obligations under this Agreement in a manner consistent in all material respects with the
Pharmaceutical Industry Principles for Responsible Supply Chain Management, as codified as of the date of this Agreement at https:/pscinitiative.org/principles and Customer’s Supplier Conduct Principles (as set forth on Schedule 5.7), and will
provide Customer with periodic access upon reasonable notice to any of its facilities where it is performing under this Agreement to enable Customer to verify compliance with this Section 5.9(b). 

  
 14 

 (c) Supplier represents and warrants to Customer that Supplier has and Supplier covenants that it
will continue to have a documented, comprehensive environment, health and safety policy which addresses, among other things, its ongoing commitment to environmental stewardship and elimination of workplace injuries and illnesses. Upon
Customer’s request, Supplier shall provide Customer with evidence of implementation of such policy and agrees to provide information related to the environmental impact of any Product (or any materials used therein) including but not limited to
Supplier’s greenhouse gas emissions water use, waste generation, recycled content, amounts of regulated chemicals in a product, and disposal information. 

(d) As and when they become available, Supplier shall identify and bring to Customer’s attention Product options that have a reduced
environment, health and/or safety impact. In the event Supplier receives an Order for Product for which Supplier has an option with a reduced environmental footprint or a more favorable health and safety profile, Supplier shall promptly notify
Customer of such option(s). Supplier shall discuss with Customer the feasibility, efficacy, regulatory and cost implications of any of the foregoing alternate Product options and shall provide such options if and as directed by Customer. Supplier
shall also identify and bring to Customer’s attention any take-back programs available. 
 (e) All information provided pursuant to
this Section 5.9 is, or shall be, complete, truthful and accurate. In the event of any such information provided changes, Supplier shall immediately notify Customer, in writing with reasonable detail, of such change. 

5.10 Cooperation/Coordination with Third Party Vendors. Supplier acknowledges that Customer may, during the course of this Agreement,
work with one or more other third party consultants and service providers from time to time in connection with this Agreement. Supplier shall reasonably cooperate with all such third parties as Customer may request from time to time. 

5.11 Cooperation with Governmental Authorities 

(a) Supplier will cooperate with Customer’s reasonable requests with respect to any planned or actual audit or inspection related to this
Agreement by any Regulatory Authority, including the FDA, or relating to any government investigation. If Supplier is notified that such audit or inspection will take place, Supplier will promptly notify Customer. Supplier will promptly provide to
Customer any audit or inspection findings or report related to this Agreement. 
 (b) Supplier will cooperate with Customer in making
submissions (including submissions for marketing approval) to regulatory authorities relating to any documentation, Product or information related to the Product that Supplier uses, produces or gives to Customer under this Agreement. 

(c) Supplier will cooperate with Customer in responding to all requests for information from, and in making all legally required filings with,
Governmental Authorities having jurisdiction to make such requests or require such filings. 
 5.12 Compliance with Global Trade Control
Laws. In accordance with and in no way limiting Section 5.3, with respect to all activities performed under this Agreement, Supplier represents, warrants, and covenants that: 

(a) It will not, directly or knowingly indirectly, conduct activities under this Agreement (i) in a Restricted Market, (ii) with
companies, organizations, or Governmental Authorities located in a Restricted Market; or (iii) with individuals that are ordinarily resident in a Restricted Market; 

  
 15 

 (b) Supplier is not a Restricted Party and is not 50% or more owned or otherwise Controlled by a
Restricted Party. With respect to activities performed under this Agreement, Supplier covenants that it will not directly or knowingly indirectly engage or delegate any activities to a Restricted Party under this Agreement; 

(c) In the event that Supplier breaches any of the foregoing representations under this Section 5.12, Supplier will, as promptly as
practicable after obtaining actual knowledge of such breach, inform Customer in writing and suspend all activities that caused such breach, including but not limited to making any payments under this Agreement in breach of this Section 5.12,
until Customer agrees to move forward and end the suspension of the affected activities; and 
 (d) Supplier will not knowingly transfer any
goods, software, technology, or services to Customer that are (i) controlled under the U.S. International Traffic in Arms Regulations or at a level other than EAR99 under the U.S. Export Administration Regulations; or (ii) specifically
identified as an E.U. Dual-Use Item, except, in each case of (i) and (ii), pursuant to valid export licenses, approvals or license exceptions and with prior written notice to Customer which shall be via
email to gtc@pfizer.com. 
 6. TERM 

6.1 Initial Term. This Agreement is entered into as of the Effective Date and shall remain in effect until the fifth (5th) anniversary thereof (the “Initial Term”) unless terminated earlier as provided herein. At least six (6) months prior to the expiration of the Initial Term or the applicable
Extension Period (as defined below), as the case may be, Customer and Supplier shall commence discussions regarding Prices and other terms applicable to any subsequent Extension Period. The Initial Term and all Extension Periods shall be referred to
collectively as the “Term” of this Agreement. 
 6.2 Extension Periods. A Customer Party may extend this Agreement
for additional consecutive one (1) year periods (each an “Extension Period”) by giving Supplier written notice of such extension of the Agreement at least one hundred twenty (120) days prior to the expiration of the
Initial Term or the applicable Extension Period, as the case may be. The Parties agree to negotiate in good faith any adjustments to the Prices applicable to such Extension Periods. Supplier may elect not to extend this Agreement by providing two
(2) years’ advance written notice to Customer of its intention not to extend the Agreement as provided in this Section 6.2, in which case this Agreement shall terminate at the end of the Initial Term or then-current Extension Period,
as applicable, but in all cases subject to Supplier’s obligations under Section 7.7. 
 7. TERMINATION 

7.1 Termination for Cause. Either Party may terminate this Agreement and/or any or all Orders immediately upon written notice to the
other Party in the event of a material breach by the other Party of any term of this Agreement which breach remains uncured for thirty (30) days following written notice to such breaching Party of such material breach. Notwithstanding the
foregoing, if such material breach, by its nature, cannot be cured, the non-breaching Party may terminate this Agreement immediately upon written notice to the breaching Party. 

7.2 Termination by Customer for Convenience. Solely with respect to Orders that are not binding within the 12-month rolling forecast (as described in Section 2.5(a)), a Customer Party may terminate all or any part of any or all such Orders at any time without cause and in its sole discretion upon [***] days’
prior written notice. In the event of such termination of any or all such Orders described in the immediately preceding sentence by a Customer Party for convenience, such Customer Party shall 

  
 16 

 
pay Supplier in accordance with the terms of this Agreement for Products satisfactorily delivered, in each case in conformance with the terms of this Agreement and the applicable Order prior to
the effective date of such termination. For clarity, Supplier shall not be entitled to any losses, fees, surcharges, costs or special, indirect, incidental, consequential or other damages, including, without limitation, contribution to lost profits
or unabsorbed overhead, as a result of any portion of the Products not delivered under Orders permitted to be cancelled hereunder. 
 7.3
Termination for Insolvency. In the event that a Party hereto: (i) becomes insolvent, or institutes or has instituted against it a petition for bankruptcy or is adjudicated bankrupt; or (ii) executes a bill of sale, deed of trust, or
a general assignment for the benefit of creditors; or (iii) is dissolved or transfers a substantial portion of its assets to a third party; or (iv) has a receiver appointed for the benefit of its creditors, or has a receiver appointed on
account of insolvency (in the case of (i), (ii), (iii) or (iv) such party shall be referred to as the (“Insolvent Party”); then the Insolvent Party shall immediately notify the other Party of such event and such other Party
shall be entitled to: (a) terminate this Agreement and/or any or all Orders for cause immediately upon written notice to the Insolvent Party; or (b) request that the Insolvent Party or its successor provide adequate assurances of continued
and future performance in form and substance acceptable to such other Party, which shall be provided by the Insolvent Party within ten days of such request, and the other Party may terminate this Agreement and/or any or all Orders for cause
immediately upon written notice to the Insolvent Party in the event that the Insolvent Party fails to provide such assurances acceptable to the other Party within such ten day period. 

7.4 Termination for Breach of Anti-bribery/Anti-Corruption or Global Trade Control Representations. Customer may terminate this
Agreement and/or any or all Orders effective upon ten (10) days’ written notice to Supplier, if: (i) Supplier breaches any of the representations and warranties set forth in Sections 5.3, 5.6 or 5.12 in any material respect, or
(ii) Customer obtains actual knowledge (a) that payments in violation of the FCPA are being or have been made or offered to Government Officials or any other person by the Supplier or those acting on behalf of the Supplier under this
Agreement, or (b) that the Supplier or those acting on behalf of the Supplier with respect to this Agreement has, in violation of the FCPA, accepted any payment, item, or benefit, regardless of value, as an improper inducement to award, obtain
or retain business or otherwise gain or grant an improper business advantage from or to any other person or entity. Further, in the event of such termination, and without limiting Customer’s other rights or remedies (subject to any limitations
in this Agreement), Supplier shall not be entitled to any further payment (other than for conforming Product delivered under outstanding Orders), regardless of any activities undertaken or agreements with additional third parties entered into by
Supplier prior to such termination. 
 7.5 Effect of Termination 

(a) Any termination of this Agreement shall not terminate the Parties’ obligations to each other under existing Orders unless and until
such Orders are themselves terminated in accordance with this Agreement. 
 (b) In the event that a single Customer Party terminates the
Agreement, the Term of the Agreement shall continue with respect to the other Customer Party, and the Parties shall renegotiate in good faith the adjustments and discounts set forth in Schedule 3.1 hereof. 

(c) The termination or expiration of this Agreement shall not affect the survival and continuing validity of the following Sections:
Section 4.1 (Inspection; Rejection of Non-conforming Product), Section 4.2 (Refund, Replacement of Non-conforming Product), Section 8 (Intellectual
Property), Section 9 (Indemnification; Liens; Insurance), Section 10 (Confidentiality), Section 13 (Records and Audits), Section 14 (Miscellaneous) and any other provision which is expressly or by implication intended to continue
in force after such termination or expiration. 

  
 17 

 7.6 Obligations of Parties Upon Termination or Expiration. Upon termination or expiration
of this Agreement, (i) Supplier shall at Customer’s option and pursuant to Customer’s instructions, return and/or destroy all Customer-related information and materials in whatever form in Supplier’s possession (except for such
information that Supplier is required to retain pursuant to Section 13.1) and provide written certification to Customer of such return and/or destruction of Customer’s information and materials within thirty (30) days of such
termination or expiration; (ii) Customer shall at Supplier’s request return and/or destroy all Confidential Information of Supplier in whatever form in Customer’s possession, (iii) except in cases of termination by Supplier under
Section 7.1 (in which case Customer shall have no right to continued supply), at Customer’s option and pursuant to Customer’s instructions, Supplier shall provide Customer with sufficient supply of Product (y) to meet the
then-current twelve (12) month Forecast, or (z) if no such Forecast is in effect as of the date of expiration or termination, to meet the aggregate quantity of Product supplied hereunder in the twelve (12) months prior to the date of
expiration or termination; and (iv) Supplier shall take such further action that Customer may reasonably request to minimize delay and expense arising from such termination; provided that the foregoing shall not require Supplier to license any
Intellectual Property or transfer any technology or know-how to Customer or any third person. Supplier acknowledges that its failure to comply with this provision may cause Customer irreparable harm for which
Customer may not have any adequate remedy at law, and that Customer shall be entitled to seek equitable relief, including injunction and specific performance, as a remedy for any actual or threatened breach by Supplier of its obligations under this
Section (without proof of actual damages or harm, and not subject to any requirement for the securing or posting of any bond in connection therewith). 

8. INTELLECTUAL PROPERTY 
 8.1
Customer Property 
 (a) Without limiting Customer’s rights in any Intellectual Property developed or acquired outside of this
Agreement, all materials, inventions, know-how, methodologies, trademarks, specifications, information, data, writings and other property in any form whatsoever, (i) which are provided or otherwise made
available to Supplier by or on behalf of Customer, and (ii) which were owned or Controlled by Customer prior to being provided or made available to Supplier, shall remain the property of Customer (the “Customer Property”).
Without limiting the foregoing, Customer shall retain all rights, title and interest in and to such Customer Property, including without limitation all patents, copyrights, trademarks, trade secrets and other Intellectual Property and proprietary
rights and any ideas, concepts, designs, inventions and expressions embodied in or appurtenant to such Customer Property. Customer hereby grants to Supplier a non-transferable,
non-exclusive license to use any Customer Property supplied to Supplier hereunder solely to the extent and for the duration necessary to enable Supplier to perform its obligations hereunder. Supplier shall not
acquire any other right, title or interest in or to the Customer Property as a result of its performance hereunder. For purposes of this Section 8.1(a) and Section 8.2(a) below, “Controlled” means, with respect to any material,
item of information or Intellectual Property right, the possession, whether by ownership or license, of the right to grant a license or other right with respect thereto without violating the contractual or Intellectual Property rights of any third
party and without having to pay any additional amounts to a third party. 

  
 18 

 (b) Any improvements or modifications to Customer Property (“Improvements”) that
are developed, conceived, created, authored or reduced to practice by or on behalf of Supplier during the Term and related to the activities carried out in the performance of this Agreement, either alone or in concert with Customer or any third
parties, shall be the exclusive property of Customer, and Customer shall own all rights, title and interest in and to such Improvements. Such ownership shall inure to the benefit of Customer from the date of the conception, creation, reduction to
practice or fixation in a tangible medium of expression of the Improvements. All copyrightable aspects of such Improvements shall be considered “Work Made For Hire” as defined in §101 of the 1976 Copyright Act (as amended), and all
rights, title and interest in and to such Improvements hereby is and shall be transferred to and vested in Customer without any additional compensation to Supplier or its Personnel. In the event that any Improvements do not qualify to be Work Made
For Hire, Supplier hereby irrevocably transfers, assigns and conveys, and shall cause its Personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to such Improvements to Customer, at no cost to Customer, free and
clear of any liens and encumbrances, and Supplier agrees to execute, and shall cause its Personnel to execute, all documents necessary, in Customer’s discretion, to do so. All such assignments shall include, but are not limited to, those
relating to existing or prospective copyrights, patent rights and all other Intellectual Property rights in any country. Supplier also agrees that it shall, and shall cause its Personnel to, promptly notify Customer of any Intellectual Property
developed or otherwise included as Improvements, and to provide reasonable assistance, at Customer’s expense, in the procurement or enforcement of any such Intellectual Property. In producing Improvements, Supplier shall not incorporate into
such Improvements any Supplier Property or other materials in which Supplier or any third party has pre-existing proprietary rights (collectively, “Pre-Existing
Materials”), except such Pre-Existing Materials as may be approved in advance by Customer in writing. 

8.2 Supplier Property. 

(a) Without limiting Customer’s rights in any Intellectual Property developed or acquired outside of this Agreement, all materials,
inventions, know-how, methodologies, trademarks, information, Specifications, data, writings and other property, in any form whatsoever, (i) which are provided to Customer by or on behalf of Supplier, or
which were used by Supplier with respect to the performance of its obligations hereunder, and (ii) which were owned or Controlled by Supplier prior to its performance hereunder, shall remain the property of Supplier (the “Supplier
Property”). Customer shall acquire no right, title or interest in Supplier Property as a result of Supplier’s or Customer’s performance hereunder. 

(b) Any improvements or modifications to Supplier Property together with all Intellectual Property rights therein and thereto (collectively,
“Supplier Improvements”) that are developed, conceived, created, authored or reduced to practice by or on behalf of Customer, or developed by Supplier based on input or suggestions by Customer, during the Term and in each case
related to activities carried out in the performance of this Agreement, either alone or in concert with Supplier or any third parties, shall be the exclusive property of Supplier, and Supplier shall own all rights, title and interest in and to such
Supplier Improvements. Such ownership shall inure to the benefit of Customer from the date of the conception, creation, reduction to practice or fixation in a tangible medium of expression of the Supplier Improvements. Customer hereby irrevocably
transfers, assigns and conveys, and shall cause its personnel to irrevocably transfer, assign and convey, all rights, title and interest in and to such Supplier Improvements to Supplier, at no cost to Supplier, free and clear of any liens and
encumbrances, and Customer agrees to execute, and shall cause its personnel to execute, all documents necessary, in Supplier’s discretion, to do so. All such assignments shall include, but are not limited to, those relating to existing or
prospective copyrights, patent rights and all other Intellectual Property rights in any country. Customer also agrees that it shall, and shall cause its personnel to, promptly notify Supplier of any Intellectual Property developed or otherwise
included as Supplier Improvements, and to provide reasonable assistance, at Supplier’s expense, in the procurement or enforcement of any such Intellectual Property. 

  
 19 

 (c) Supplier hereby grants to Customer during the Term (i) a
non-exclusive, irrevocable, perpetual (with respect to Products supplied hereunder), worldwide license under the Licensed Patent Rights and Intellectual Property rights in Supplier Improvements and Pre-existing Materials, in each case embodied in or necessary to use the Product, to manufacture or have manufactured CleanCap mRNA, utilizing Product supplied hereunder and to use such CleanCap mRNA to research,
develop, manufacture, have manufactured, use, have used, offer for sale, have offered for sale, sell, have sold, import, export and/or otherwise commercialize Licensee Products, and a (ii) non-exclusive, non-transferable, worldwide, royalty-free right and license to Customer to display Supplier’s trademarks adopted and designated by Supplier from time to time solely to perform Customer’s rights under this
Agreement. Any rights granted by Supplier to Customer pursuant to this Article 8 shall in no event confer to Customer the right to, and Customer shall not, modify, resell, manufacture, or have modified, resold, or manufactured, CleanCap Reagent.

 (d) This Agreement confers rights to Customer to grant sublicenses of the rights granted Customer under this Section 8 for Licensee
Products (through multiple tiers) to collaboration partners (collectively the “Sublicensee”), allowing Sublicensee to research, develop, make, have made, use, have used, offer for sale, have offered for sale, sell, have sold,
import, export and/or otherwise commercialize, Licensee Products by Sublicensee and/or through Sublicensee’s Affiliates and/or third parties. For the avoidance of doubt, the Parties agree that the sublicensing rights under this
Section 8.2(d), shall also provide Sublicensee the right to have Licensee Products manufactured by a contract manufacturer or to involve a service provider in the development and manufacture of Licensee Products. Subject to
Supplier’s prior written consent, Customer shall notify Supplier in writing within thirty (30) days of granting of any sublicense hereunder and provide to Supplier the applicable Sublicensee’s name and affirm the sublicense was
granted for a permitted purpose under this Agreement. 
 8.3 Limited Right to Use Property. Subject to the provisions of
Section 8.1 and Section 8.2, nothing set forth in this Agreement shall be construed to grant to a Party any title, right or interest in or to any Intellectual Property Controlled by the other Party or any of its Affiliates. Use by a Party
of any such Intellectual Property of the other Party shall be limited exclusively to its performance of this Agreement. 
  

	9.	 INDEMNIFICATION; LIENS; INSURANCE 

9.1 Indemnification by Supplier 

(a) To the fullest extent permitted by Law, Supplier shall defend, indemnify, and hold harmless Customer, its Affiliates and its and their
respective directors, officers, employees, agents and representatives from and against any and all Losses arising out of or relating to any and all claims, liabilities, liens, demands, obligations, actions, proceedings, suits or causes of action of
every kind in each case in connection with a third party claim to the extent arising out of or related to: 
  

	 	(i)	 Supplier’s supply of Non-conforming Product;

  

	 	(ii)	 claims made by employees or representatives of Supplier or its subcontractors based on employment contract, or
any Laws prohibiting discrimination in employment, or under worker’s compensation or similar Laws; 

  
 20 

	 	(iii)	 failure of Supplier or its Personnel to comply with any Law, including but not limited to Environmental Laws,
failure to pay taxes, duties, or fees, or to comply with employee safety regulations; 

  

	 	(iv)	 infringement or improper appropriation or use by Supplier or its Personnel of trade secrets, proprietary
information, know-how, copyrights, trademarks, patents, patented inventions or any other Intellectual Property or proprietary rights of any third party; 

 

	 	(vi)	 injury to or death of any person or damage to any property resulting from and/or caused by Supplier or its
Personnel in connection with the performance or non-performance of Supplier’s obligations under this Agreement; or 

 

	 	(vii)	 negligence, recklessness, willful misconduct, fraud or bad faith of Supplier or its Personnel in connection
with the performance or non-performance of this Agreement. 

 (b) Notwithstanding
the foregoing, Supplier shall not be liable for Losses to the extent such Losses are caused by the negligence, recklessness or willful misconduct of Customer. Furthermore, Supplier shall not be liable for losses pursuant to Section 9.1(a)(iv)
to the extent such infringement or improper appropriation or use is caused by Customer’s unauthorized modification of the Product. 

(c) Without limiting any other of Supplier’s obligations or Customer’s rights under this Agreement, including, without limitation,
Section 11.1, if the Product, or any part thereof, becomes or, in Supplier’s reasonable opinion, is likely to become the subject of an infringement, misappropriation or misuse claim, suit or cause of action, Supplier, at its expense,
promptly shall either (a) procure for Customer the right to continue using such Product free of any liability for infringement, misappropriation or misuse; or (b) replace or modify such Product with a
non-infringing substitute of equivalent or better functionality that is reasonably satisfactory to Customer. In the event Supplier is unable, after exercising its best efforts, to implement one of the options
set forth in subsection (a) or (b) above within thirty (30) days after becoming aware of any such claim, suit or cause of action, or the likelihood of any claim, suit or cause of action, then Customer shall have the right to return the
affected Product and/or cease using the affected Product and any services associated therewith, and Supplier promptly shall refund to Customer an amount equal to the total amount paid by Customer to Supplier for the affected Product. This
Section 9.1 shall survive the expiration or termination of this Agreement. 
 9.2 Indemnification by Customer 

(a) To the fullest extent permitted by Law, Customer shall defend, indemnify, and hold harmless Supplier, its Affiliates and its respective
directors, officers, employees, agents and representatives from and against any and all Losses arising out of or relating to any and all claims, liabilities, liens, demands, obligations, actions, proceedings, suits or causes of action of every kind
in each case in connection with a third party claim to the extent arising out of or related to: 
  

	 	(i)	 Customer’s misuse of Product; 

 

	 	(ii)	 product liability, safety, or other claims relating to Customer Product; 

  
 21 

	 	(iii)	 claims made by employees or representatives of Customer or by Customer’s subcontractors based on
employment contract, or any Laws prohibiting discrimination in employment, or under worker’s compensation or similar Laws; 

  

	 	(iv)	 failure of Customer or its personnel to comply with any Law, including but not limited to Environmental Laws,
failure to pay taxes, duties, or fees, or to comply with employee safety regulations; 

  

	 	(v)	 infringement or improper appropriation or use by Customer or its Personnel of trade secrets, proprietary
information, know-how, copyrights, trademarks, patents, patented inventions or any other Intellectual Property or proprietary rights of any third party in connection with any Customer Product other than to the
extent resulting from Customer’s use of Supplier Property; 

  

	 	(vi)	 injury to or death of any person or damage to any property resulting from and/or caused by Customer or its
personnel in connection with the performance or non-performance of Customer’s obligations under this Agreement; or 

 

	 	(vii)	 negligence, recklessness, willful misconduct, fraud or bad faith of Customer or its personnel in connection
with the performance or non-performance of this Agreement. 

 (b) Notwithstanding
the foregoing, Customer shall not be liable for Losses to the extent such Losses are caused by the negligence, recklessness or willful misconduct of Supplier. 

9.3 Indemnification Procedures. A Party entitled to indemnification hereunder (the “Indemnified Party”) shall inform
the Party with a duty to indemnify hereunder (the “Indemnifying Party”) of any claim for which it intends to invoke indemnification and, at the Indemnifying Party’s request and expense, reasonably cooperate with the
Indemnifying Party in the defense of such claim. The Indemnifying Party shall assume, at its cost and expense, the defense of such claim through legal counsel reasonably acceptable to the Indemnified Party, except that the Indemnified Party may, at
its option and expense, select and be represented by separate counsel, in which case the Indemnifying Party will reasonably cooperate with the Indemnified Party and such separate counsel. The Indemnifying Party shall have control over the suit or
proceedings, including the right to settle; provided, however, that the Indemnifying Party will keep the Indemnified Party reasonably informed of the status of such suit or proceedings and that Supplier will not, absent the written consent of the
Indemnified Party, consent to the entry of any judgment or enter into any settlement that (1) provides for any admission of liability on the part of the Indemnified Party, its Affiliates or its or their respective directors, officers,
employees, agents or representatives, as the case may be, or relief other than the payment of monetary damages for which the Indemnifying Party shall be solely liable; (2) adversely affects the rights of the Indemnified Party under this
Agreement; or (3) does not release the Indemnified Party, its Affiliates and its and their respective directors, officers, employees, agents and representatives from all liability in respect thereof. In no event shall the Indemnified Party, its
Affiliates or its or their respective directors, officers, employees, agents or representatives be liable for any claims that are compromised or settled in violation of this Section 9.3. 

  
 22 

 9.4 Exclusion of Damages. EXCEPT AS EXPRESSLY PROVIDED IN THIS AGREEMENT, NEITHER PARTY
SHALL BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL, PUNITIVE, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, WITHOUT LIMITATION, DAMAGES RESULTING FROM LOSS OF USE, LOSS OF PROFITS, INTERRUPTION OR LOSS OF BUSINESS, LOST
GOODWILL, LOST REVENUE AND LOST OPPORTUNITY) ARISING OUT OF ANY OF THE TERMS OR CONDITIONS OF THIS AGREEMENT OR WITH RESPECT TO ITS PERFORMANCE HEREUNDER. The foregoing exclusion of damages shall apply (1) even if a Party had or should have had
knowledge, actual or constructive, of the possibility of such damages, (2) whether a claim is based on breach of contract, breach of warranty, tort (including negligence), product liability, strict liability or otherwise, and
(3) notwithstanding any failure of essential purpose of any limited remedy herein. Notwithstanding the foregoing exclusion of damages, each Party shall be liable to the other for indirect, incidental or consequential damages to the extent:
(i) arising out of a breach of confidentiality or a violation of the other Party’s Intellectual Property rights, (ii) arising out of each Party’s obligations to indemnify for third party claims, (iii) awarded for bodily
injury, death or damage to real or personal property of a Party or any third party, provided that the recovering Party shall not be entitled to damages for loss of profits, interruption or loss of business, lost goodwill, lost revenue and lost
opportunity, or (iv) resulting from a Party’s gross negligence or willful misconduct. 
 9.5 Liens. It is Customer’s
expectation that funds paid by Customer to Supplier will be used to pay for materials consumed by Supplier. To the extent permitted by Law, Supplier, for itself and all of its suppliers and subcontractors and all of its and their respective
laborers, mechanics and materialmen, hereby waives and agrees not to claim any lien against the Customer but shall rely solely upon the general credit of Customer. 

9.6 Insurance 
 (a)
Maintenance of Coverage. During the Term, Supplier shall provide and maintain such insurance coverage, in minimum types and amounts as described below in this Section 9.4, as will protect it and Customer (including its employees,
directors, officers and agents) from all claims which may arise out of or result from Supplier’s performance under this Agreement, whether such operations are conducted by Supplier itself or by its Personnel or by anyone directly or indirectly
employed by any of them, or by anyone for whose acts or omissions they may be liable. Supplier will permit no subcontractor to commence or continue the performance of any services, obligations or other activities hereunder unless such subcontractor
is and remains insured as outlined in this Section 9.4. Any and all deductibles for such insurance policies shall be assumed by, for the account of, and at Supplier’s sole risk. All deductibles and self-insured retention amounts must be
acceptable to and approved, in writing (if required), by Customer. 
 (b) Waiver of Subrogation. Such insurance policies shall be
primary and non-contributing with respect to any other similar insurance policies available to Customer. Except for Workers Compensation/Employers’ Liability and Errors & Omissions/Professional
Liability, all such policies shall include Customer and its Affiliates and any other such entities as Customer may reasonably request, as additional insureds. All such polices shall provide a waiver of subrogation in favor of Customer and its
Affiliates. 
 (c) Insurance Certificate. Prior to commencement of this Agreement and annually thereafter, Supplier shall furnish to
Customer original certificates and additional insurance endorsements evidencing the specified insurance coverage. If requested by Customer, copies of the insurance policies themselves will be provided. Such certificates shall provide that not less
than thirty (30) days’ prior written notice of any policy cancellation or material change shall be given to Customer. The Certificate(s) of Insurance shall be signed by a person authorized by the insurer(s) to bind coverage on its (their)
behalf. Supplier shall provide, pay for, and maintain in effect the policies with minimum “A-” A.M. Best rated insurance carriers, or insurance companies satisfactory to Customer. 

  
 23 

 (d) Limits. The insurance required under this Section 9.4 shall be written for not
less than any limits of liability specified herein or as required by Law, whichever is greater. Supplier shall have the right to provide the total limits required by any combination of primary and Umbrella/Excess coverage; said insurance to include,
without limitation, the following: 
  

	 	(i)	 Insurance for liability under the Workers’ Compensation or occupational disease laws of any state or other
jurisdiction in which services are performed (or be a qualified self-insurer in those states and jurisdictions) or otherwise applicable with respect to persons performing the services, and Employer’s Liability insurance covering all claims by
or in respect to the employees of Supplier and all subcontractors, providing: 

  

	 	1.	 Coverage for the statutory limits of all claims under the applicable State Workers’ Compensation Act or
Acts. If the scope of work will result in exposures under the U.S. Longshoreman’s Act and its amendments (work dockside or on water), the Jones Act (involving seaman, masters and crew of vessels) or the Federal Employer’s Liability Act
(railroad exposure), coverage shall be extended to include insurance coverages mandated thereby; 

  

	 	2.	 Employer’s Liability Insurance with a limit of not less than [***]; 

 

	 	3.	 Voluntary Compensation insurance covering all employees not subject to the applicable state Workers’
Compensation Act or Acts. 

  

	 	(ii)	 Commercial General Liability insurance with the following limits and forms/endorsements: 

 

			
	 Each Occurrence
	  	[***]
		
	 Products and Completed Operations Aggregate
	  	[***]

  

	 	(a)	 Occurrence form including premises and operations coverage, products and completed operations, broad form
property damage, coverage for independent contractors, personal injury coverage, blanket contractual liability, explosion, collapse, and underground (“XCU”) and watercraft liability coverage if services are performed on or near a
body of water. 

  

	 	(b)	 Products and completed operations coverage shall be maintained for a period of not less than three
(3) years following the date of the last delivery of Product to Customer hereunder. 

  

	 	(c)	 ISO Endorsement CG20101185 (or its equivalent) including Customer as additional insureds with respect to any
legal liability of Customer, arising out of Supplier’s performance. 

  

	 	(iii)	 Automobile and Truck Liability Insurance: $1,000,000 combined single limit for bodily injury and property
damage arising out of all owned, non-owned and hired vehicles, including coverage for all automotive and truck equipment used in the performance of this Agreement and including the loading and unloading of
same. 

  
 24 

	 	(iv)	 Umbrella (Excess) Liability Coverage (follow form) in an amount not less than $4,000,000 per occurrence and in
the aggregate. 

  

	 	(v)	 If Supplier has care, custody or control of Customer property or inventory, Supplier shall be responsible for
any loss or damage to it, and provide all risk Property Coverage at full replacement cost for same. 

 (e) Acceptance
of Certificate. Acceptance of any insurance certificate by Customer shall not constitute acceptance of the adequacy of coverage, compliance with the requirements of this Agreement, or serve as an amendment to this Agreement. 

9.7 No Joint and Several Liability. The obligations and liabilities of Customer herein are the individual undertakings of each Customer
Party. Supplier may not proceed hereunder against a Customer Party for any claim against the other Customer Party under this Agreement and any associated Losses. 

10. CONFIDENTIALITY 
 10.1
Restricted Disclosure and Use of Confidential Information. Each Party, as a Receiving Party, shall keep, and shall cause its Personnel to keep, strictly confidential and not disclose to any third party Confidential Information of the
Receiving Party, using the same duty of care it uses with respect to its own confidential information of like type, but in no event less than a reasonable degree of care. A Receiving Party shall not use, and shall not permit its Personnel to use,
the Confidential Information of the Disclosing Party except in accordance with this Agreement. In the event a Receiving Party becomes aware of any breach of the confidentiality and non-use obligation contained
in this Section 10 by it or its Personnel, the applicable Receiving Party shall promptly notify the Disclosing Party in writing of such breach and all facts known to Receiving Party regarding same. Notwithstanding the foregoing or anything
herein to the contrary, Confidential Information (and the obligations set forth herein with respect thereto) shall not include Exempt Information. 

10.2 Permitted Disclosures. Notwithstanding the foregoing, Confidential Information may be disclosed by Receiving Party to the extent
required: (a) for the performance of Receiving Party obligations under this Agreement, subject to Section 10.3 and (b) in order to comply with any court order, statute or governmental directive, provided that in the event that such
court order, statute or governmental directive requires disclosure of Confidential Information, Receiving Party shall provide prompt notice to the Disclosing Party (except where restricted by Law) before such Confidential Information is disclosed
and cooperate with the Disclosing Party if the Disclosing Party seeks protective order or other appropriate remedy for such Confidential Information, and if no such protective order or other remedy is obtained, Receiving Party will furnish only that
portion of the Confidential Information which it is advised by its counsel it is legally required to furnish. 
 10.3 Precautions. In
order to comply with its confidentiality and non-use obligations, Receiving Party shall take at least the following precautions: (a) Receiving Party shall exercise all reasonable efforts to prevent
unauthorized employees and unauthorized third parties from gaining access to Confidential Information (and in no event less than reasonable care); (b) Receiving Party shall disclose Confidential Information only to such of its Personnel who have a
need to know such Confidential Information to fulfill Receiving Party’s obligations under this Agreement; provided, however, before any disclosure of Confidential Information, Receiving Party shall bind its Personnel receiving such Confidential
Information to a written agreement of confidentiality at least as restrictive as this Agreement; and (c) prior to any disclosure, Receiving Party shall instruct its Personnel of the confidential nature of, and to maintain the confidentiality
of, the Confidential Information. Receiving Party shall be responsible for all actions of its Personnel, including, without limitation, any breach of the terms hereof. 

  
 25 

 10.4 Survival. The Parties hereby agree that the Confidential Non-Disclosure Agreement by and among the Parties dated April 17, 2020 is hereby terminated, with respect to the subject matter herein, by the Parties as of the Effective Date hereof. Any Confidential
Information previously exchanged between the Parties under the terms of such shall hereinafter be deemed governed by the terms of this Agreement. Upon the earlier of a Disclosing Party’s request or termination or expiration of this Agreement,
Receiving Party shall promptly return to Disclosing Party all of the Confidential Information. However, Receiving Party may retain one copy of any document containing Confidential Information in its confidential files for so long as necessary and
for the sole purpose of determining its continuing obligations under this Agreement; provided, however, that the terms of this Section 10 shall continue to apply with regard to any such Confidential Information retained by Receiving Party.
Notwithstanding Receiving Party’s return of the Confidential Information, Receiving Party will continue to be bound by its obligation of confidentiality and non-use under this Agreement for a period of
five (5) years after the later of termination or expiration of this Agreement, except with respect to any information that constitutes a trade secret (as defined under Law), in which case Receiving Party will continue to be bound by its
obligation of confidentiality and non-use under this Agreement for so long as such information continues to constitute a trade secret, but in no event for a period of less than the five (5) year period
specified immediately above. 
 11. SUPPLY ASSURANCE 

11.1 Supplier shall have a written business continuity plan and disaster recovery plan system that (a) aims to assure supply of Product to
customers in the event of a business interruption, including any disruption resulting from a Force Majeure Event, to the extent commercially reasonable; (b) identifies and protects critical dependencies; and (c) is consistent with current
business continuity standards (e.g., ISO22301). Supplier agrees to partner with the Customer, upon reasonable request, in completing integrated business continuity recovery exercises. Supplier shall immediately notify Customer in the event of a
potential disruption to critical dependencies and in advance of any potential implementation of the business continuity plan. 
 12. [INTENTIONALLY
OMITTED.] 
 13. RECORDS AND AUDITS 

13.1 Records. Supplier will maintain complete and accurate Records. Any Records that are financial in nature such as, but not limited
to, time sheets, billing records, invoices, payment applications, payments of consultants and subcontractors and receipts relating to reimbursable expenses shall be maintained in accordance with generally accepted accounting principles. Supplier
shall maintain all Records in accordance with the terms of the Quality Agreement or as otherwise may be required by Law. 
 13.2
Audits. Each Customer Party or its representatives, including its external auditors, may audit any Records of Supplier, including all Records related to Supplier’s compliance with Laws, at any time during the Term and the six
(6) year period following expiration or termination of this Agreement, during normal business hours and upon reasonable notice to Supplier. No audits hereunder or under the Quality Agreement shall include in its scope any financial matters
relating to Supplier or its cost to produce Product; provided that the Parties shall adjust the foregoing appropriately upon any agreement hereunder with respect to cost reductions requiring cost transparency. Supplier shall make any Records readily
available for such audit, and Customer or its representatives may view any and all such Records in connection with any such audit. 

  
 26 

 13.3 Disclosure and Reporting By Customer. Customer may disclose in any lawful manner the
terms of the underlying agreement, the support or funding that Customer is providing, and any other information to the extent necessary for Customer to meet its obligations under the Transparency Laws. Supplier will, at the request of Customer,
provide Customer with complete and accurate information about payments or other transfers of value reportable under Transparency Laws and agrees to (and will cause its Personnel to) cooperate with Customer’s collection and disclosure of
information necessary for Customer to meet its obligations under any Transparency Laws. 
 14. MISCELLANEOUS 

14.1 No Publicity. Supplier shall not use the name, trade name, service marks, trademarks, trade dress or logos of Customer (or any of
its Affiliates) in publicity releases, advertising or any other publication, nor identify Customer as a customer, without Customer’s prior written consent in each instance. The Parties intend to issue a press release regarding the Parties’
relationship hereunder upon Regulatory Approval of any Customer Product, but no such press release will be published by either Party without the prior consent of the other Party (not to be unreasonably withheld or delayed). 

14.2 Governing Law; Dispute Resolution; Venue 

(a) Negotiations of Dispute. Prior to commencing any litigation with respect to any controversy, claim, counterclaim, dispute,
difference or misunderstanding arising out of or relating to the interpretation or application of any term or provisions of this Agreement or an Order or any related documents, a Party shall provide written notice to the other Party of the existence
of such dispute. The Parties shall for a period of thirty (30) days following such notice enter into good faith discussions and negotiations in an attempt to resolve such dispute. If, by the end of such thirty (30) day period, unless such
period is extended by mutual agreement of the Parties, the Parties have been unable to resolve such dispute, either Party may initiate litigation. The procedures specified in this Section 14.2 is a precondition to the initiation of litigation
by a Party, in connection with disputes between the Parties arising out of or relating to this Agreement and any Order; provided, however, that a Party may: (i) seek a preliminary injunction or other preliminary judicial relief, without
attempting to resolve such dispute as provided in this Section, if in its judgment such action is necessary to avoid irreparable harm; or (ii) institute formal proceedings to avoid the expiration of any applicable limitations period. Further,
the requirement to attempt to resolve a dispute in accordance with this Section 14.2 does not affect a Party’s right to terminate this Agreement or an Order as provided in Section 7.1, and neither Party shall be required to follow
these procedures prior to terminating the Agreement. 
 (b) Governing Law. The validity, interpretation and performance of this
Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to the principles of conflicts of law. THE PARTIES EXPRESSLY AGREE THAT THE APPLICATION OF THE UNITED NATIONS CONVENTION ON CONTRACTS
FOR THE INTERNATIONAL SALE OF GOODS (1980) IS SPECIFICALLY EXCLUDED AND SHALL NOT APPLY TO THIS AGREEMENT. 
 (c) Venue. All
actions and proceedings under this Agreement shall be brought exclusively in a state or federal court of competent subject matter jurisdiction in the County of New Castle in the State of Delaware. Each Party hereby irrevocably waives (i) any
objection which it may have at any time to 

  
 27 

 
the venue of the proceedings in any such court, (ii) any claim that such proceedings have been brought in an inconvenient forum and (iii) the right to object, with respect to such
proceedings, that such court does not have any jurisdiction over such Party. IN ANY CONTROVERSY OR CLAIM, WHETHER BASED IN CONTRACT, TORT OR OTHER LEGAL THEORY, ARISING OUT OF OR RELATING TO THIS AGREEMENT, ITS NEGOTIATION, ENFORCEABILITY OR
VALIDITY, OR THE PERFORMANCE OR BREACH HEREOF OR THE RELATIONSHIPS ESTABLISHED HEREUNDER, ALL PARTIES HEREBY WAIVE THEIR RIGHT TO TRIAL BY JURY. 

14.3 Relationship of the Parties. The relationship hereby established between Customer and Supplier is solely that of independent
contractors. Supplier has no authority to act or make any agreements or representations on behalf of Customer. This Agreement is not intended to create, and shall not be construed as creating, between Supplier and Customer, the relationship of
principal and agent, employer and employee, joint venturers, co-partners, or any other such relationship, the existence of which is expressly denied. No employee or agent engaged by Supplier shall be, or shall
be deemed to be, an employee or agent of Customer and nor entitled to any benefits that Customer provides to its own employees. 
 14.4
Notices. Any notice required to be given hereunder shall be in writing and deemed to have been sufficiently given, (i) when delivered in person, (ii) on the next Business Day after mailing by overnight courier service, or, where
overnight courier service is unavailable, by other expedited delivery provided by a recognized express courier, or (iii) when delivered via e-mail, provided the original is delivered via one of the
preceding methods on or prior to the fifth (5th) Business Day after transmission of the e-mail, to the addresses specified below. Each notice shall specify the name and date of and parties to this Agreement.

 If to Pfizer: 
 and a copy
(which shall not constitute notice) to: 
 If to BioNTech: 

with a copy (which shall not constitute notice) to: 
  

			
	 If to Supplier:
	  	 TriLink BioTechnologies Inc.
 10770 Wateridge
Circle
 Suite 200
 San Diego, CA 92121

Attn:
 E-MAIL
ADDRESS:

 with copies (which shall not constitute notice) to: 

 

			
		 	 Maravai LifeSciences, Inc.
 10770 Wateridge
Circle
 Suite 200
 San Diego, CA 92121

Attn:
 E-MAIL
ADDRESS:

  
 28 

			
		  	 and
  

Kirkland & Ellis LLP
 300 North La Salle Street

Chicago, IL 60654
 Attn:

 
 E-MAIL ADDRESS:

 Either Party may, by notice to the other Party, change the addresses and names given above. 

13.5 Assignment/ Subcontracting. Supplier shall not assign any of its rights or delegate or subcontract any of its duties and
obligations under this Agreement without the prior written consent of Customer (not to be unreasonably withheld), provided that, Supplier may, without requiring the consent of Customer: (a) delegate its duties or obligations to a subcontractor
as specifically set forth in an Order or to any pre-approved subcontractor identified in the Quality Agreement, and (b) assign this Agreement to any acquirer or successor in connection with a sale of all
or substantially all of the business of Supplier to which this Agreement relates, whether by sale of ownership interests or assets, merger, or otherwise. Any such attempted assignment of rights or delegation or subcontracting of duties in
contravention of the above shall be void and ineffective. Any such delegation or subcontracting permitted hereunder shall not relieve Supplier of its responsibilities and liabilities hereunder and Supplier shall remain liable to Customer for the
conduct and performance of each permitted assignee, delegate and subcontractor hereunder. 
 14.6 Binding Effect. This Agreement
shall apply to, inure to the benefit of and be binding upon the Parties hereto and their respective successors and permitted assigns. The Parties agree that, except with respect to an Affiliate of Customer who is party to an Order as provided in
Section 2.1, this Agreement is not intended by any Party to give any benefits, rights, privileges, actions or remedies to any person or entity, partnership, firm or corporation as a third party beneficiary or otherwise under any theory of law.
It being understood and agreed that an Affiliate of Customer who is party to an Order as provided in Section 2.1 shall be deemed an intended third party beneficiary of this Agreement for purposes of that particular Order. 

14.7 Force Majeure. Subject to Supplier’s obligations under Section 11.1, no Party shall be liable for any failure to perform
or any delays in performance, and no Party shall be deemed to be in breach or default of its obligations set forth in this Agreement, if, to the extent and for so long as, such failure or delay is due to any causes that are beyond its reasonable
control and not to its acts or omissions, including, without limitation, such causes as acts of God, natural disasters, epidemic or pandemic, flood, severe storm, earthquake, civil disturbance, lockout, riot, order of any court or administrative
body, embargo, acts of government, war (whether or not declared), acts of terrorism, or other similar causes, in each case to the extent beyond its reasonable control and causing failure or delay in performance (“Force Majeure
Event”). For clarity, raw material price increases, unavailability of raw materials, and labor disputes shall not be deemed a Force Majeure Event. In the event of a Force Majeure Event, the Party prevented from or delayed in performing
shall promptly give notice to the other Party and shall use commercially reasonable efforts to avoid or minimize the delay. The Party affected by the other Party’s delay may elect to: (a) suspend performance and extend the time for
performance for the duration of the Force Majeure Event, or (b) cancel all or any part of the unperformed part of this Agreement and/or any Orders. 

  
 29 

 14.8 Severability. If and solely to the extent that any court or tribunal of competent
jurisdiction holds any provision of this Agreement to be unenforceable in a final non-appealable order, such unenforceable provision shall be stricken and the remainder of this Agreement shall not be affected
thereby. In such event, the Parties shall in good faith attempt to replace any unenforceable provision of this Agreement with a provision that is enforceable and that comes as close as possible to expressing the intention of the original provision.

 14.9 Non-Waiver; Remedies. A waiver by any Party of any term or condition of this
Agreement in any instance shall not be deemed or construed to be a waiver of such term or condition for the future, or of any subsequent breach thereof. All remedies specified in this Agreement shall be cumulative and in addition to any other rights
or remedies available at law or in equity. Customer shall be entitled to seek equitable relief, including injunction and specific performance, as a remedy for any actual or threatened breach by Supplier of its obligations under this Agreement
(without proof of actual damages or harm, and not subject to any requirement for the securing or posting of any bond in connection therewith). 

14.10 Further Documents. Each Party hereto agrees to execute such further documents and take such further steps as may be reasonably
necessary or desirable to effectuate the purposes of this Agreement. 
 14.11 Headings. Headings of sections or other parts of this
Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement or change the meaning of this Agreement. 

14.12 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall constitute an original and all of
which together shall constitute one and the same agreement, and shall become effective when signed by each of the Parties hereto and delivered to the other Party in accordance with the means set forth in Section 14.4 or by reliable electronic
means (with receipt electronically confirmed). 
 14.13 Electronic Delivery and Storage. Delivery of a signed Agreement by reliable
electronic means, including facsimile or email (with receipt electronically confirmed), shall be an effective method of delivery of the executed Agreement. This Agreement may be stored by electronic means and either an original or an electronically
stored copy of this Agreement can be used for all purposes, including in any proceeding to enforce the rights and/or obligations of the Parties to this Agreement. 

14.14 Entire Agreement; Amendments. This Agreement, together with any attachments and amendments hereto, constitutes the entire
agreement of the Parties with respect to its subject matter and merges and supersedes all prior discussions and writings with respect to thereto. No modification or alteration of this Agreement shall be binding upon the Parties unless contained in a
writing signed by a duly authorized agent for each respective Party and specifically referring hereto. 
 14.15 Rule of Construction.
The Parties have participated jointly in the negotiation and drafting of this Agreement. In the event that an ambiguity or question of intent or interpretation arises, this Agreement shall be construed as if drafted jointly by the Parties and no
presumption or burden of proof shall arise favoring or disfavoring any Party by virtue of the authorship of any of the provisions of this Agreement. 

*         *         *
        *         * 
 Signature Page Follows 

  
 30 

 IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed and delivered as of the
Effective Date. 
  

							
	TriLink Biotechnologies, LLC	 	 Pfizer Inc.

									
					
	By:	 	/s/ Brian Neel	 		 	 By:
	 	/s/ Mike McDermott
	Name:	 	Brian Neel	 		 	Name:	 	Mike McDermott
	Title:	 	COO	 		 	Title:	 	President PGS
				
		 		 		 	BioNTech SE
					
		 		 		 	By:	 	/s/ Sierk Poetting
		 		 		 	Name:	 	Sierk Poetting
		 		 		 	Title:	 	Managing Director

  
 31

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00316-of-00352.parquet"}]]